<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Med</journal-id><journal-id journal-id-type="iso-abbrev">J Clin Med</journal-id><journal-id journal-id-type="pmc-domain-id">2745</journal-id><journal-id journal-id-type="pmc-domain">jclinmed</journal-id><journal-id journal-id-type="publisher-id">jcm</journal-id><journal-title-group><journal-title>Journal of Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2077-0383</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12429834</article-id><article-id pub-id-type="pmcid-ver">PMC12429834.1</article-id><article-id pub-id-type="pmcaid">12429834</article-id><article-id pub-id-type="pmcaiid">12429834</article-id><article-id pub-id-type="doi">10.3390/jcm14175932</article-id><article-id pub-id-type="publisher-id">jcm-14-05932</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Systematic Review</subject></subj-group></article-categories><title-group><article-title>Reconstruction After Wide Excision of the Nail Apparatus in the Treatment of Melanoma: A Systematic Literature Review</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Chouquet</surname><given-names initials="L">Luc</given-names></name><xref rid="af1-jcm-14-05932" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Boukari</surname><given-names initials="F">Feriel</given-names></name><xref rid="af2-jcm-14-05932" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Balaguer</surname><given-names initials="T">Thierry</given-names></name><xref rid="af1-jcm-14-05932" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0528-4829</contrib-id><name name-style="western"><surname>Montaudi&#233;</surname><given-names initials="H">Henri</given-names></name><xref rid="af2-jcm-14-05932" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Camuzard</surname><given-names initials="O">Olivier</given-names></name><xref rid="af1-jcm-14-05932" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lupon</surname><given-names initials="E">Elise</given-names></name><xref rid="af1-jcm-14-05932" ref-type="aff">1</xref><xref rid="af3-jcm-14-05932" ref-type="aff">3</xref><xref rid="c1-jcm-14-05932" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Schmitt-Egenolf</surname><given-names initials="M">Marcus</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-jcm-14-05932"><label>1</label>Plastic Surgery Department, Institut Universitaire Locomoteur et du Sport, Pasteur 2 Hospital, University C&#244;te d&#8217;Azur, 06100 Nice, France; <email>chouquet.l@chu-nice.fr</email> (L.C.); <email>balaguer.t@chu-nice.fr</email> (T.B.); <email>camuzard.o@chu-nice.fr</email> (O.C.)</aff><aff id="af2-jcm-14-05932"><label>2</label>Dermatology Department, L&#8217;Archet Hospital, University C&#244;te d&#8217;Azur, 06100 Nice, France; <email>boukari.f@chu-nice.fr</email> (F.B.); <email>montaudie.h@chu-nice.fr</email> (H.M.)</aff><aff id="af3-jcm-14-05932"><label>3</label>Laboratory of Molecular PhysioMedicine (LP2M), CNRS, University C&#244;te d&#8217;Azur, 06100 Nice, France</aff><author-notes><corresp id="c1-jcm-14-05932"><label>*</label>Correspondence: <email>elupon@mgh.harvard.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>14</volume><issue>17</issue><issue-id pub-id-type="pmc-issue-id">496787</issue-id><elocation-id>5932</elocation-id><history><date date-type="received"><day>22</day><month>7</month><year>2025</year></date><date date-type="rev-recd"><day>12</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>19</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>22</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 11:25:14.803"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jcm-14-05932.pdf"/><abstract><p><bold>Background/Objectives</bold>: Historically, the treatment of subungual melanoma was based on amputation of the affected digit. However, extended wide local excision of the nail apparatus is now considered the conservative gold standard for in situ or minimally invasive forms. There are many after wide local excision reconstruction techniques, but few studies have objectively compared their results. The objectives were to carry out a systematic review of reconstruction after wide local excision reconstructions in the treatment of subungual melanoma. <bold>Methods:</bold> This systematic review was conducted following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. An exhaustive search was conducted in the PubMed (Medline), Embase, and Cochrane Library databases, up to July 2025. Articles reporting reconstructions after wide local excision for subungual melanoma of the fingers or toes were included. Clinical, technical, and outcome data were analyzed. <bold>Results:</bold> The literature review comprised 24 articles on 373 patients, primarily those with in situ subungual melanoma. Reconstruction was most often performed using total skin grafts, sometimes combined with dermal matrices. Some authors used local or free flaps. Few studies used validated functional scores. Local recurrences were significant, affecting 18% of patients and requiring secondary amputation. <bold>Conclusions:</bold> Nail apparatus reconstructions are primarily indicated for in situ or minimally invasive subungual melanomas. Immediate reconstruction carries a risk of performing the reconstruction over residual tumor tissue, particularly in the case of invasive melanomas. Reconstructive techniques, such as full-thickness skin grafts and the use of dermal matrices, can provide satisfactory functional and aesthetic outcomes. However, objective evaluations of these results remain limited, and better standardization of clinical practice, along with prospective studies, is needed to refine long-term outcome assessment.</p></abstract><kwd-group><kwd>subungual melanoma</kwd><kwd>nail reconstruction</kwd><kwd>wide local excision</kwd><kwd>nail apparatus</kwd><kwd>nail melanoma</kwd></kwd-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-jcm-14-05932"><title>1. Introduction</title><p>Melanoma is a significant public health concern, with over 330,000 new cases and more than 58,000 deaths per year worldwide by 2022 [<xref rid="B1-jcm-14-05932" ref-type="bibr">1</xref>]. One of the major prognostic factors for cutaneous melanoma is the Breslow index, which corresponds to the measured vertical thickness of the tumor, expressed in millimeters, from the top of the granular layer of the epidermis (or the base of an ulcer, if present) to the deepest point of tumor invasion in the dermis or subcutis. A greater Breslow thickness is strongly associated with a higher risk of recurrence and poorer survival outcomes [<xref rid="B2-jcm-14-05932" ref-type="bibr">2</xref>,<xref rid="B3-jcm-14-05932" ref-type="bibr">3</xref>]. However, subsequent genomic studies have suggested that this paradigm may not fully apply to nail apparatus melanoma, which appears genetically distinct from acral and other cutaneous melanomas, potentially influencing prognostic interpretation [<xref rid="B4-jcm-14-05932" ref-type="bibr">4</xref>]. Subungual melanomas (SUM) belong to the subcategory of acral-lentiginous melanomas, which represent approximately 0.7 to 3.5% of all melanomas in Caucasians but can be as high as 50% in Asian or African Caribbean subjects [<xref rid="B5-jcm-14-05932" ref-type="bibr">5</xref>,<xref rid="B6-jcm-14-05932" ref-type="bibr">6</xref>]. SUM is most frequently found in the nail matrix, where it manifests as a dark, heterochromatic, longitudinal melanonychia with ill-defined contours that can sometimes invade adjacent skin folds. Historically, treatment was based on systematic amputation of the affected digit, often resulting in significant functional loss and cosmetic damage, which had a considerable impact on quality of life [<xref rid="B7-jcm-14-05932" ref-type="bibr">7</xref>]. Today, it has been established that in situ or minimally invasive melanomas can be treated conservatively, by wide local excision (WLE) of the nail apparatus [<xref rid="B8-jcm-14-05932" ref-type="bibr">8</xref>,<xref rid="B9-jcm-14-05932" ref-type="bibr">9</xref>,<xref rid="B10-jcm-14-05932" ref-type="bibr">10</xref>]. SUM involves excision of the entire nail with margins generally between 5 and 10 mm, and immediate or delayed reconstruction [<xref rid="B11-jcm-14-05932" ref-type="bibr">11</xref>]. The choice of reconstruction technique is complex and not consensual, particularly when the excision is large, local functional requirements are essential, and scarring threatens to cause cosmetic damage with social repercussions [<xref rid="B12-jcm-14-05932" ref-type="bibr">12</xref>,<xref rid="B13-jcm-14-05932" ref-type="bibr">13</xref>].</p><p>To better identify the possibility of reconstruction, we conducted a systematic review of the literature on surgical techniques used in nail reconstruction following SUM.</p><p>The objective of this review was to systematically evaluate the oncologic, functional, and aesthetic outcomes of conservative versus amputation surgical techniques for subungual melanoma, focusing on recurrence rates, reconstruction methods, and long-term quality-of-life impact.</p></sec><sec id="sec2-jcm-14-05932"><title>2. Materials and Methods</title><list list-type="bullet"><list-item><p>Literature search</p></list-item></list><p>This systematic review was conducted following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines [<xref rid="B14-jcm-14-05932" ref-type="bibr">14</xref>]. An exhaustive search was conducted in PubMed/MEDLINE, Embase, Scopus, and Web of Science from their creation to July 2025. The keywords used were (&#8216;Nail apparatus Melanoma&#8217; OR &#8216;Nail Matrix Melanoma&#8217; OR &#8216;Subungual Melanoma&#8217;) AND (&#8216;reconstruction&#8217; OR &#8220;flap&#8221; OR &#8216;dermal matrix&#8217; OR &#8216;skin graft&#8217; OR &#8216;healing&#8217;). Searches in Scopus and Web of Science did not identify additional eligible articles beyond those retrieved from PubMed and Embase. A manual search for the bibliographies of relevant articles completed the analysis. Only articles in English, Spanish, and French were retained. After an initial screening of titles and abstracts, duplicates, irrelevant studies, literature reviews, animal studies, and cases of amputation were excluded. The full texts were then analyzed, and purely anatomical studies were excluded. The institutional ethics committee has approved this research project.</p><list list-type="bullet"><list-item><p>Study Selection</p></list-item></list><p>Studies were included according to the following criteria:<list list-type="simple"><list-item><label>-</label><p>Type of study: case series, case reports, cohort studies, and randomized controlled trials of nail reconstruction after melanoma removal.</p></list-item><list-item><label>-</label><p>Participants: adult or pediatric patients undergoing reconstruction after removal of a subungual melanoma of the upper or lower limb.</p></list-item><list-item><label>-</label><p>Results reported: type of melanoma and excision (margins), reconstruction technique, time frame, adjuvant treatments, complications, functional and aesthetic results, patient satisfaction, recurrences, and length of follow-up.</p></list-item></list></p><p>Two reviewers (L.C. and E.L.) independently examined the titles and abstracts and then the full texts of potentially eligible articles. Disagreements were resolved by discussion or arbitration by a third reviewer (O.C.).</p><list list-type="bullet"><list-item><p>Data Collection</p></list-item></list><p>Due to the heterogeneity of the studies (in terms of design, population, and techniques), a meta-analysis was not feasible. A narrative summary was produced, and the results were presented in the form of summary tables, which brought together the main characteristics and conclusions of the included studies. Data were independently extracted by two reviewers using a standardized data collection form. Extracted variables included study design, population characteristics, surgical technique, follow-up duration, recurrence, functional and aesthetic outcomes, and complications.</p><list list-type="bullet"><list-item><p>Data synthesis and analysis</p></list-item></list><p>Given the heterogeneity of study designs and outcome measures, a meta-analysis was not preferred. Instead, a narrative synthesis of the included studies was carried out. The data were organized and summarized in tabular form, highlighting the characteristics of the included studies, key findings, and outcomes of interest. In addition to extracting clinical and technical variables, we assessed the methodological quality of each included study. Risk of bias was evaluated independently by two reviewers using the Newcastle&#8211;Ottawa Scale (NOS) for observational studies and the Joanna Briggs Institute (JBI) checklists for case series or single case reports; disagreements were resolved by consensus. For each study, we also recorded the method used to assess functional and/or aesthetic outcomes, specifying whether validated patient-reported outcome measures (PROMs) were employed.</p></sec><sec sec-type="results" id="sec3-jcm-14-05932"><title>3. Results</title><list list-type="bullet"><list-item><p>Study selection</p></list-item></list><p>The study selection process is summarized in the PRISMA 2020 flow diagram (<xref rid="jcm-14-05932-f001" ref-type="fig">Figure 1</xref>). An initial search conducted in the PubMed and TRIP databases identified 593 articles. After removing duplicates and excluding articles written in languages other than French, English, or Spanish, 547 unique references were included for screening. Title and abstract review led to the selection of 45 articles for full-text assessment. Of these, 21 were excluded: 16 focused on cases managed by amputation, 1 provided insufficient data, and 4 dealt with acral lentiginous melanomas at unrelated anatomical sites. In total, 24 studies met the predefined inclusion and exclusion criteria and were included in the analysis (<xref rid="jcm-14-05932-f001" ref-type="fig">Figure 1</xref>).</p><list list-type="bullet"><list-item><p>Study characteristics</p></list-item></list><p>Of the 24 studies selected, 18 were case series [<xref rid="B15-jcm-14-05932" ref-type="bibr">15</xref>,<xref rid="B16-jcm-14-05932" ref-type="bibr">16</xref>,<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>,<xref rid="B18-jcm-14-05932" ref-type="bibr">18</xref>,<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>,<xref rid="B21-jcm-14-05932" ref-type="bibr">21</xref>,<xref rid="B22-jcm-14-05932" ref-type="bibr">22</xref>,<xref rid="B23-jcm-14-05932" ref-type="bibr">23</xref>,<xref rid="B24-jcm-14-05932" ref-type="bibr">24</xref>,<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>,<xref rid="B26-jcm-14-05932" ref-type="bibr">26</xref>,<xref rid="B27-jcm-14-05932" ref-type="bibr">27</xref>,<xref rid="B28-jcm-14-05932" ref-type="bibr">28</xref>,<xref rid="B29-jcm-14-05932" ref-type="bibr">29</xref>,<xref rid="B30-jcm-14-05932" ref-type="bibr">30</xref>,<xref rid="B31-jcm-14-05932" ref-type="bibr">31</xref>,<xref rid="B32-jcm-14-05932" ref-type="bibr">32</xref>], and 6 were single case reports [<xref rid="B33-jcm-14-05932" ref-type="bibr">33</xref>,<xref rid="B34-jcm-14-05932" ref-type="bibr">34</xref>,<xref rid="B35-jcm-14-05932" ref-type="bibr">35</xref>,<xref rid="B36-jcm-14-05932" ref-type="bibr">36</xref>,<xref rid="B37-jcm-14-05932" ref-type="bibr">37</xref>,<xref rid="B38-jcm-14-05932" ref-type="bibr">38</xref>]. All the studies were retrospective (<italic toggle="yes">n</italic> = 23), except for one study, which was a prospective case series [<xref rid="B38-jcm-14-05932" ref-type="bibr">38</xref>]. All the studies were published between 2003, for the oldest [<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>], and 2023, for the most recent [<xref rid="B22-jcm-14-05932" ref-type="bibr">22</xref>]. <xref rid="jcm-14-05932-t001" ref-type="table">Table 1</xref> summarizes the characteristics of the included studies.</p><p>Quality assessment revealed an overall moderate methodological level across the included studies. Most clearly stated their inclusion criteria and surgical protocols, but sample sizes were generally small, and comparative designs were rare. According to the Newcastle&#8211;Ottawa Scale (NOS) and Joanna Briggs Institute (JBI) checklist, depending on study design, methodological quality was rated as moderate in 13 studies, moderate-to-high in 8, and high in 3. Only one study [<xref rid="B24-jcm-14-05932" ref-type="bibr">24</xref>] employed psychometrically validated patient-reported outcome measures (QuickDASH and Foot Function Index); all others relied on non-validated Likert-type or clinical scales for functional and aesthetic evaluation. Outcome assessment was heterogeneous, most often based on qualitative surgeon or patient appraisal (e.g., overall satisfaction, pain reports, or return to daily activities). Full details of the quality appraisal, including individual study ratings and notes on outcomes, are available in <xref rid="app1-jcm-14-05932" ref-type="app">Supplementary Table S1</xref>.</p><list list-type="bullet"><list-item><p>Demographic characteristics</p></list-item></list><p>Sample sizes varied from study to study, ranging from 1 to 140 [<xref rid="B22-jcm-14-05932" ref-type="bibr">22</xref>] participants, for a total of 373 patients, with an average age of 53.4 years (4 to 81 years). Women predominated, comprising 252 of the 373 patients, which represents a sex ratio of 67%.</p><p>One study did not specify the sex of the patients [<xref rid="B28-jcm-14-05932" ref-type="bibr">28</xref>].</p><list list-type="bullet"><list-item><p>Anatomical localization</p></list-item></list><p>Of the articles included for which the location was specified, 91 patients had involvement of the lower limb, including 25 cases involving the hallux when this information was available, and 164 patients had involvement of the upper limb, including 50 cases involving the thumb. However, for 118 patients, the precise anatomical location was not reported. Four studies did not mention the location of the lesion at all [<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>,<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B24-jcm-14-05932" ref-type="bibr">24</xref>,<xref rid="B27-jcm-14-05932" ref-type="bibr">27</xref>].</p><list list-type="bullet"><list-item><p>Melanoma type</p></list-item></list><p>Regarding the diagnostic phase, the majority of articles [<xref rid="B18-jcm-14-05932" ref-type="bibr">18</xref>,<xref rid="B22-jcm-14-05932" ref-type="bibr">22</xref>,<xref rid="B24-jcm-14-05932" ref-type="bibr">24</xref>,<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>,<xref rid="B26-jcm-14-05932" ref-type="bibr">26</xref>,<xref rid="B28-jcm-14-05932" ref-type="bibr">28</xref>,<xref rid="B30-jcm-14-05932" ref-type="bibr">30</xref>,<xref rid="B32-jcm-14-05932" ref-type="bibr">32</xref>,<xref rid="B33-jcm-14-05932" ref-type="bibr">33</xref>,<xref rid="B35-jcm-14-05932" ref-type="bibr">35</xref>,<xref rid="B36-jcm-14-05932" ref-type="bibr">36</xref>,<xref rid="B37-jcm-14-05932" ref-type="bibr">37</xref>] reported that an initial biopsy was performed. Only one article [<xref rid="B34-jcm-14-05932" ref-type="bibr">34</xref>] mentioned an immediate biopsy-exeresis, while two studies [<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>,<xref rid="B38-jcm-14-05932" ref-type="bibr">38</xref>] noted the absence of a biopsy. The presence or absence of prior biopsy was not specified in nine articles [<xref rid="B15-jcm-14-05932" ref-type="bibr">15</xref>,<xref rid="B16-jcm-14-05932" ref-type="bibr">16</xref>,<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>,<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B21-jcm-14-05932" ref-type="bibr">21</xref>,<xref rid="B23-jcm-14-05932" ref-type="bibr">23</xref>,<xref rid="B27-jcm-14-05932" ref-type="bibr">27</xref>,<xref rid="B29-jcm-14-05932" ref-type="bibr">29</xref>,<xref rid="B31-jcm-14-05932" ref-type="bibr">31</xref>]. When the degree of local invasion was reported, the majority of melanomas were in situ (<italic toggle="yes">n</italic> = 65). Among the invasive forms, five cases had a Breslow index of less than 1 mm, two cases had a Breslow index between 1 and 3 mm, and two cases had a Breslow index of more than 3 mm. Six studies did not mention the stage of the melanoma [<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>,<xref rid="B22-jcm-14-05932" ref-type="bibr">22</xref>,<xref rid="B23-jcm-14-05932" ref-type="bibr">23</xref>,<xref rid="B24-jcm-14-05932" ref-type="bibr">24</xref>].</p><list list-type="bullet"><list-item><p>Margins</p></list-item></list><p>These margins were not tumor resection margins in the strict sense of the term, but margins for resection of the entire nail apparatus, generally set at 5 mm in the majority of studies [<xref rid="B15-jcm-14-05932" ref-type="bibr">15</xref>,<xref rid="B16-jcm-14-05932" ref-type="bibr">16</xref>,<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>,<xref rid="B18-jcm-14-05932" ref-type="bibr">18</xref>,<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>,<xref rid="B21-jcm-14-05932" ref-type="bibr">21</xref>,<xref rid="B24-jcm-14-05932" ref-type="bibr">24</xref>,<xref rid="B26-jcm-14-05932" ref-type="bibr">26</xref>,<xref rid="B36-jcm-14-05932" ref-type="bibr">36</xref>,<xref rid="B37-jcm-14-05932" ref-type="bibr">37</xref>,<xref rid="B38-jcm-14-05932" ref-type="bibr">38</xref>]. However, some publications have reported wider margins of 10 mm [<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>,<xref rid="B33-jcm-14-05932" ref-type="bibr">33</xref>,<xref rid="B35-jcm-14-05932" ref-type="bibr">35</xref>,<xref rid="B37-jcm-14-05932" ref-type="bibr">37</xref>], while others have recommended narrower margins of 3 mm [<xref rid="B22-jcm-14-05932" ref-type="bibr">22</xref>,<xref rid="B34-jcm-14-05932" ref-type="bibr">34</xref>]. The standard Mohs micrographic surgery technique was used in two studies [<xref rid="B27-jcm-14-05932" ref-type="bibr">27</xref>,<xref rid="B32-jcm-14-05932" ref-type="bibr">32</xref>], and the delayed Mohs or &#8216;Slow Mohs&#8217; technique was also mentioned in two other publications [<xref rid="B27-jcm-14-05932" ref-type="bibr">27</xref>,<xref rid="B32-jcm-14-05932" ref-type="bibr">32</xref>]. Finally, one study reported the use of extemporaneous anatomopathological examination to check the margins of excision of the nail apparatus [<xref rid="B30-jcm-14-05932" ref-type="bibr">30</xref>].</p><list list-type="bullet"><list-item><p>Strategy for reconstruction</p></list-item></list><p>Full-thickness skin graft (FTSG) was the preferred reconstruction technique in the majority of studies [<xref rid="B15-jcm-14-05932" ref-type="bibr">15</xref>,<xref rid="B16-jcm-14-05932" ref-type="bibr">16</xref>,<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>,<xref rid="B18-jcm-14-05932" ref-type="bibr">18</xref>,<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>,<xref rid="B21-jcm-14-05932" ref-type="bibr">21</xref>,<xref rid="B23-jcm-14-05932" ref-type="bibr">23</xref>,<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>,<xref rid="B26-jcm-14-05932" ref-type="bibr">26</xref>,<xref rid="B29-jcm-14-05932" ref-type="bibr">29</xref>,<xref rid="B32-jcm-14-05932" ref-type="bibr">32</xref>,<xref rid="B33-jcm-14-05932" ref-type="bibr">33</xref>,<xref rid="B34-jcm-14-05932" ref-type="bibr">34</xref>], involving a total of 112 patients. Of these, ten studies [<xref rid="B16-jcm-14-05932" ref-type="bibr">16</xref>,<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>,<xref rid="B18-jcm-14-05932" ref-type="bibr">18</xref>,<xref rid="B21-jcm-14-05932" ref-type="bibr">21</xref>,<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>,<xref rid="B26-jcm-14-05932" ref-type="bibr">26</xref>,<xref rid="B29-jcm-14-05932" ref-type="bibr">29</xref>,<xref rid="B32-jcm-14-05932" ref-type="bibr">32</xref>,<xref rid="B33-jcm-14-05932" ref-type="bibr">33</xref>,<xref rid="B34-jcm-14-05932" ref-type="bibr">34</xref>] reported that FTSG was performed immediately, at the same time as the extended excision, in 52 patients. In contrast, seven studies reported delayed reconstruction, involving 55 patients [<xref rid="B16-jcm-14-05932" ref-type="bibr">16</xref>,<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>,<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>,<xref rid="B26-jcm-14-05932" ref-type="bibr">26</xref>,<xref rid="B30-jcm-14-05932" ref-type="bibr">30</xref>,<xref rid="B31-jcm-14-05932" ref-type="bibr">31</xref>,<xref rid="B32-jcm-14-05932" ref-type="bibr">32</xref>,<xref rid="B34-jcm-14-05932" ref-type="bibr">34</xref>,<xref rid="B35-jcm-14-05932" ref-type="bibr">35</xref>,<xref rid="B38-jcm-14-05932" ref-type="bibr">38</xref>]. The immediate or delayed nature of the reconstruction was not specified in four publications [<xref rid="B15-jcm-14-05932" ref-type="bibr">15</xref>,<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>,<xref rid="B23-jcm-14-05932" ref-type="bibr">23</xref>,<xref rid="B27-jcm-14-05932" ref-type="bibr">27</xref>].</p><p>Only the series by Crisan et al. reported the use of a negative pressure dressing in preparation for delayed FTSG [<xref rid="B31-jcm-14-05932" ref-type="bibr">31</xref>]. FTSG was used exclusively in 71 patients [<xref rid="B15-jcm-14-05932" ref-type="bibr">15</xref>,<xref rid="B16-jcm-14-05932" ref-type="bibr">16</xref>,<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>,<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>,<xref rid="B21-jcm-14-05932" ref-type="bibr">21</xref>,<xref rid="B23-jcm-14-05932" ref-type="bibr">23</xref>,<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>,<xref rid="B26-jcm-14-05932" ref-type="bibr">26</xref>,<xref rid="B31-jcm-14-05932" ref-type="bibr">31</xref>,<xref rid="B32-jcm-14-05932" ref-type="bibr">32</xref>,<xref rid="B33-jcm-14-05932" ref-type="bibr">33</xref>,<xref rid="B34-jcm-14-05932" ref-type="bibr">34</xref>], combined with a dermal matrix in 5 cases [<xref rid="B30-jcm-14-05932" ref-type="bibr">30</xref>,<xref rid="B35-jcm-14-05932" ref-type="bibr">35</xref>,<xref rid="B38-jcm-14-05932" ref-type="bibr">38</xref>], and combined with a perionychium flap in 43 patients [<xref rid="B18-jcm-14-05932" ref-type="bibr">18</xref>,<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B21-jcm-14-05932" ref-type="bibr">21</xref>]. One study used a delayed thin skin graft after Mohs micrographic analysis [<xref rid="B27-jcm-14-05932" ref-type="bibr">27</xref>].</p><p>Concerning the use of dermal matrices, three articles [<xref rid="B30-jcm-14-05932" ref-type="bibr">30</xref>,<xref rid="B35-jcm-14-05932" ref-type="bibr">35</xref>,<xref rid="B38-jcm-14-05932" ref-type="bibr">38</xref>] were concerned, involving a total of five patients, for whom the dermal matrix was placed at the same time as the resection, and a second stage with the placement of an FTSG three weeks after the first stage was carried out. Only the PELNAC<sup>&#174;</sup> matrix was used, except in one study where INTEGRA<sup>&#174;</sup> was used [<xref rid="B35-jcm-14-05932" ref-type="bibr">35</xref>].</p><p>With regard to flaps, only Motta et al. and Lee et al. [<xref rid="B24-jcm-14-05932" ref-type="bibr">24</xref>,<xref rid="B37-jcm-14-05932" ref-type="bibr">37</xref>] utilized free flaps, respectively, a free toe transfer in 1 case, and ultra-thin superficial circumflex iliac artery perforator flaps (SCIP) in 41 cases. In contrast, eight studies mentioned local flaps, six of which were associated with an FTSG [<xref rid="B15-jcm-14-05932" ref-type="bibr">15</xref>,<xref rid="B18-jcm-14-05932" ref-type="bibr">18</xref>,<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>,<xref rid="B21-jcm-14-05932" ref-type="bibr">21</xref>,<xref rid="B32-jcm-14-05932" ref-type="bibr">32</xref>] and two used exclusive Foucher flap reconstruction [<xref rid="B28-jcm-14-05932" ref-type="bibr">28</xref>,<xref rid="B36-jcm-14-05932" ref-type="bibr">36</xref>]. Local flaps combined with FTSG were most often perionychium advancement or palmar advancement flaps [<xref rid="B18-jcm-14-05932" ref-type="bibr">18</xref>,<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B21-jcm-14-05932" ref-type="bibr">21</xref>]; one case report proposed a cross-finger flap [<xref rid="B32-jcm-14-05932" ref-type="bibr">32</xref>]. Finally, two studies favored directed healing only [<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>,<xref rid="B27-jcm-14-05932" ref-type="bibr">27</xref>], and one study did not mention the surgical technique for reconstruction [<xref rid="B37-jcm-14-05932" ref-type="bibr">37</xref>].</p><list list-type="bullet"><list-item><p>Carcinologic complications</p></list-item></list><p>The most frequently observed complication was melanoma recurrence, which was reported in 11 studies [<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>,<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>,<xref rid="B21-jcm-14-05932" ref-type="bibr">21</xref>,<xref rid="B22-jcm-14-05932" ref-type="bibr">22</xref>,<xref rid="B23-jcm-14-05932" ref-type="bibr">23</xref>,<xref rid="B24-jcm-14-05932" ref-type="bibr">24</xref>,<xref rid="B26-jcm-14-05932" ref-type="bibr">26</xref>,<xref rid="B27-jcm-14-05932" ref-type="bibr">27</xref>,<xref rid="B28-jcm-14-05932" ref-type="bibr">28</xref>,<xref rid="B31-jcm-14-05932" ref-type="bibr">31</xref>,<xref rid="B32-jcm-14-05932" ref-type="bibr">32</xref>] involving a total of 67 patients. Of these, 13 required secondary amputation of the affected digit [<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>,<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>,<xref rid="B21-jcm-14-05932" ref-type="bibr">21</xref>,<xref rid="B26-jcm-14-05932" ref-type="bibr">26</xref>,<xref rid="B27-jcm-14-05932" ref-type="bibr">27</xref>,<xref rid="B28-jcm-14-05932" ref-type="bibr">28</xref>,<xref rid="B31-jcm-14-05932" ref-type="bibr">31</xref>,<xref rid="B32-jcm-14-05932" ref-type="bibr">32</xref>]. In two cases, recurrence was linked to histologically positive excision margins, requiring amputation [<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>,<xref rid="B31-jcm-14-05932" ref-type="bibr">31</xref>].</p><p>In a further 33 cases, the status of the margins was not specified, and the treatment options varied: 11 patients underwent amputation [<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>,<xref rid="B21-jcm-14-05932" ref-type="bibr">21</xref>,<xref rid="B26-jcm-14-05932" ref-type="bibr">26</xref>,<xref rid="B27-jcm-14-05932" ref-type="bibr">27</xref>,<xref rid="B28-jcm-14-05932" ref-type="bibr">28</xref>,<xref rid="B32-jcm-14-05932" ref-type="bibr">32</xref>], and 5 underwent revision surgery of the margins [<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B24-jcm-14-05932" ref-type="bibr">24</xref>,<xref rid="B27-jcm-14-05932" ref-type="bibr">27</xref>], including 3 by deferred Mohs technique [<xref rid="B27-jcm-14-05932" ref-type="bibr">27</xref>].</p><p>Early recurrences, occurring within the first year after surgery, were reported in 15 patients [<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>,<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>]. There were two cases of SUM in situ and one invasive SUM with a thickness of 2.5 mm when specified [<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B22-jcm-14-05932" ref-type="bibr">22</xref>,<xref rid="B30-jcm-14-05932" ref-type="bibr">30</xref>]. The margins used in these studies were 3 mm in the series by Oh et al. [<xref rid="B22-jcm-14-05932" ref-type="bibr">22</xref>], 5 mm in two series [<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>,<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>], and between 5 and 10 mm in one series [<xref rid="B22-jcm-14-05932" ref-type="bibr">22</xref>]. The mean time from diagnosis to occurrence was 8 months after surgery.</p><p>Late recurrences, defined as occurring at least one year after surgery, were the most frequent, with 28 patients reported [<xref rid="B18-jcm-14-05932" ref-type="bibr">18</xref>,<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>,<xref rid="B21-jcm-14-05932" ref-type="bibr">21</xref>,<xref rid="B22-jcm-14-05932" ref-type="bibr">22</xref>,<xref rid="B24-jcm-14-05932" ref-type="bibr">24</xref>,<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>,<xref rid="B30-jcm-14-05932" ref-type="bibr">30</xref>]. These included SUM in situ in five cases [<xref rid="B24-jcm-14-05932" ref-type="bibr">24</xref>,<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>], invasive stage T1 in one case [<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>], stage T2 in two cases [<xref rid="B22-jcm-14-05932" ref-type="bibr">22</xref>,<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>], stage T3 in two cases [<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>], and stage T4 in two cases [<xref rid="B21-jcm-14-05932" ref-type="bibr">21</xref>,<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>], as specified. Among these articles, the margins used around the nail apparatus were 3 mm [<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>], 5 mm [<xref rid="B18-jcm-14-05932" ref-type="bibr">18</xref>], 6 mm [<xref rid="B24-jcm-14-05932" ref-type="bibr">24</xref>,<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>], and 5 to 10 mm [<xref rid="B22-jcm-14-05932" ref-type="bibr">22</xref>]. These recurrences were found at the surgical site in 36 cases [<xref rid="B18-jcm-14-05932" ref-type="bibr">18</xref>,<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>,<xref rid="B24-jcm-14-05932" ref-type="bibr">24</xref>,<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>], in transit in 1 case [<xref rid="B22-jcm-14-05932" ref-type="bibr">22</xref>], and reached the lymph node area concerned in 1 case [<xref rid="B21-jcm-14-05932" ref-type="bibr">21</xref>]. The average time to recurrence was 29 months after surgery.</p><p>As regards distant localization recurrence, 21 cases were described [<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B21-jcm-14-05932" ref-type="bibr">21</xref>,<xref rid="B22-jcm-14-05932" ref-type="bibr">22</xref>,<xref rid="B23-jcm-14-05932" ref-type="bibr">23</xref>,<xref rid="B24-jcm-14-05932" ref-type="bibr">24</xref>,<xref rid="B27-jcm-14-05932" ref-type="bibr">27</xref>], including the following:<list list-type="simple"><list-item><label>&#9675;</label><p>Two transit metastases, one of which was treated surgically [<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B24-jcm-14-05932" ref-type="bibr">24</xref>];</p></list-item><list-item><label>&#9675;</label><p>Ten lymph node involvement [<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B23-jcm-14-05932" ref-type="bibr">23</xref>];</p></list-item><list-item><label>&#9675;</label><p>Eleven visceral metastases, resulting in 2 deaths [<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B21-jcm-14-05932" ref-type="bibr">21</xref>,<xref rid="B22-jcm-14-05932" ref-type="bibr">22</xref>,<xref rid="B27-jcm-14-05932" ref-type="bibr">27</xref>].</p></list-item></list></p><p>These recurrences occurred on average 20 months after the first operation. They complicated a grade T3 melanoma in five cases [<xref rid="B1-jcm-14-05932" ref-type="bibr">1</xref>,<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>] and a grade T4 in one case [<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>]. The nail margins found in these cases measured 5 mm in three series, involving 18 patients [<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>,<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>].</p><list list-type="bullet"><list-item><p>Non-carcinologic post-operative complications</p><list list-type="simple"><list-item><label>&#9675;</label><p>Residual nail spicules were reported in 15 patients [<xref rid="B15-jcm-14-05932" ref-type="bibr">15</xref>,<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>,<xref rid="B18-jcm-14-05932" ref-type="bibr">18</xref>,<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>], and epidermal cysts were found in 13 patients [<xref rid="B15-jcm-14-05932" ref-type="bibr">15</xref>,<xref rid="B16-jcm-14-05932" ref-type="bibr">16</xref>,<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>,<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>]. Other adverse events included the following:</p></list-item><list-item><label>&#9675;</label><p>Ten cases of hypersensitivity to cold or shock;</p></list-item><list-item><label>&#9675;</label><p>Nine cases of graft hyperpigmentation [<xref rid="B15-jcm-14-05932" ref-type="bibr">15</xref>];</p></list-item><list-item><label>&#9675;</label><p>One case of distal interphalangeal arthritis [<xref rid="B31-jcm-14-05932" ref-type="bibr">31</xref>];</p></list-item><list-item><label>&#9675;</label><p>One flexor sheath hematoma [<xref rid="B26-jcm-14-05932" ref-type="bibr">26</xref>];</p></list-item><list-item><label>&#9675;</label><p>One case of temporary functional exclusion of the finger [<xref rid="B16-jcm-14-05932" ref-type="bibr">16</xref>].</p></list-item></list></list-item></list><p>Six studies reported no complications [<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>,<xref rid="B29-jcm-14-05932" ref-type="bibr">29</xref>,<xref rid="B30-jcm-14-05932" ref-type="bibr">30</xref>,<xref rid="B35-jcm-14-05932" ref-type="bibr">35</xref>,<xref rid="B36-jcm-14-05932" ref-type="bibr">36</xref>,<xref rid="B38-jcm-14-05932" ref-type="bibr">38</xref>], and two did not mention this criterion [<xref rid="B33-jcm-14-05932" ref-type="bibr">33</xref>,<xref rid="B37-jcm-14-05932" ref-type="bibr">37</xref>]</p><list list-type="bullet"><list-item><p>Complementary treatments</p></list-item></list><p>Most studies did not mention complementary treatments (<italic toggle="yes">n</italic> = 23).</p><p>Only one study (31) described complementary treatments, with an adjuvant course of Interferon alpha for one patient, in the context of the appearance of distant metastases. This same study also described a case of recurrence treated by radiotherapy, with an unspecified impact on the outcome of reconstruction, and a case of multiple recurrences of metastases in transit treated by iterative excision and directed healing. The sentinel node procedure was mentioned only in the study by Wollina et al., involving four patients, only one of whom had a micrometastasis [<xref rid="B23-jcm-14-05932" ref-type="bibr">23</xref>]. No study mentioned immunotherapy.</p><list list-type="bullet"><list-item><p>Functional and cosmetic results</p></list-item></list><p>Post-operative functional and cosmetic results were assessed by the examiner in six studies [<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>,<xref rid="B31-jcm-14-05932" ref-type="bibr">31</xref>,<xref rid="B33-jcm-14-05932" ref-type="bibr">33</xref>,<xref rid="B34-jcm-14-05932" ref-type="bibr">34</xref>,<xref rid="B35-jcm-14-05932" ref-type="bibr">35</xref>,<xref rid="B37-jcm-14-05932" ref-type="bibr">37</xref>], by the patient in six other studies [<xref rid="B16-jcm-14-05932" ref-type="bibr">16</xref>,<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>,<xref rid="B18-jcm-14-05932" ref-type="bibr">18</xref>,<xref rid="B24-jcm-14-05932" ref-type="bibr">24</xref>,<xref rid="B30-jcm-14-05932" ref-type="bibr">30</xref>,<xref rid="B36-jcm-14-05932" ref-type="bibr">36</xref>], and by the patient and the examiner in one study [<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>]; six studies did not mention who the assessor was [<xref rid="B15-jcm-14-05932" ref-type="bibr">15</xref>,<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B26-jcm-14-05932" ref-type="bibr">26</xref>,<xref rid="B27-jcm-14-05932" ref-type="bibr">27</xref>,<xref rid="B29-jcm-14-05932" ref-type="bibr">29</xref>,<xref rid="B35-jcm-14-05932" ref-type="bibr">35</xref>,<xref rid="B38-jcm-14-05932" ref-type="bibr">38</xref>].</p><p>Functional recovery was judged acceptable to satisfactory in eight studies, involving a total of 80 patients [<xref rid="B15-jcm-14-05932" ref-type="bibr">15</xref>,<xref rid="B16-jcm-14-05932" ref-type="bibr">16</xref>,<xref rid="B18-jcm-14-05932" ref-type="bibr">18</xref>,<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>,<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>,<xref rid="B30-jcm-14-05932" ref-type="bibr">30</xref>,<xref rid="B31-jcm-14-05932" ref-type="bibr">31</xref>], whereas it was considered total, with a return to normal function, in seven studies [<xref rid="B16-jcm-14-05932" ref-type="bibr">16</xref>,<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>,<xref rid="B26-jcm-14-05932" ref-type="bibr">26</xref>,<xref rid="B34-jcm-14-05932" ref-type="bibr">34</xref>,<xref rid="B35-jcm-14-05932" ref-type="bibr">35</xref>,<xref rid="B36-jcm-14-05932" ref-type="bibr">36</xref>,<xref rid="B37-jcm-14-05932" ref-type="bibr">37</xref>] involving 39 patients.</p><p>Regarding the cosmetic result, it was judged to be little disturbed or good in 12 articles [<xref rid="B15-jcm-14-05932" ref-type="bibr">15</xref>,<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>,<xref rid="B18-jcm-14-05932" ref-type="bibr">18</xref>,<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>,<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>,<xref rid="B28-jcm-14-05932" ref-type="bibr">28</xref>,<xref rid="B30-jcm-14-05932" ref-type="bibr">30</xref>,<xref rid="B31-jcm-14-05932" ref-type="bibr">31</xref>,<xref rid="B33-jcm-14-05932" ref-type="bibr">33</xref>,<xref rid="B35-jcm-14-05932" ref-type="bibr">35</xref>,<xref rid="B38-jcm-14-05932" ref-type="bibr">38</xref>], involving 76 patients. In contrast, it was judged to be excellent or equivalent to the previous state in four studies [<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>,<xref rid="B26-jcm-14-05932" ref-type="bibr">26</xref>,<xref rid="B36-jcm-14-05932" ref-type="bibr">36</xref>,<xref rid="B37-jcm-14-05932" ref-type="bibr">37</xref>], involving 42 patients with heterogeneous surgical techniques: exclusive directed healing [<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>], Foucher flap in the case report of one patient [<xref rid="B36-jcm-14-05932" ref-type="bibr">36</xref>], free onycho-cutaneous flap harvested from the hallux in the case report of one patient [<xref rid="B37-jcm-14-05932" ref-type="bibr">37</xref>], and six cases treated by FTSG and five by exclusive directed healing in the series by Neczyporenko et al. [<xref rid="B26-jcm-14-05932" ref-type="bibr">26</xref>]. The cosmetic result was judged to be poor in only two patients in the series by Goettmann et al. [<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>], but although directed healing was the predominant choice, the technique used for these two patients was not specified.</p><p>Only one article classified its results using validated questionnaires, that of Lee et al. [<xref rid="B24-jcm-14-05932" ref-type="bibr">24</xref>], which found an average Quick-Disabilities of the Arm, Shoulder and Hand (DASH) score of 1.3 in the 14 patients undergoing surgery on the upper limb and an average Foot Function Index (FFI) score of 3.1 in the 12 patients undergoing surgery on the lower limb.</p><p>The time to return to work was specified in two studies [<xref rid="B31-jcm-14-05932" ref-type="bibr">31</xref>,<xref rid="B35-jcm-14-05932" ref-type="bibr">35</xref>], and averaged four and six weeks, respectively, after the last operation.</p><list list-type="bullet"><list-item><p>Post-operative follow-up</p></list-item></list><p>Reported follow-up ranged from 3 months [<xref rid="B36-jcm-14-05932" ref-type="bibr">36</xref>,<xref rid="B37-jcm-14-05932" ref-type="bibr">37</xref>,<xref rid="B38-jcm-14-05932" ref-type="bibr">38</xref>] to 120 months [<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>].</p><p>The mean follow-up was 60.1 months, with a mean of 45 months.</p></sec><sec sec-type="discussion" id="sec4-jcm-14-05932"><title>4. Discussion</title><p>The management of subungual melanoma has evolved significantly since its first description in the nineteenth century [<xref rid="B39-jcm-14-05932" ref-type="bibr">39</xref>]. This topographical form appears to affect women preferentially, as indicated by our review (women authored 67% of the 24 articles included), in line with the data of Neczyporenko et al. [<xref rid="B26-jcm-14-05932" ref-type="bibr">26</xref>].</p><p>Regarding the age of onset, the fifth decade is the most frequently reported, with a few exceptions, such as the series by Lazar et al. [<xref rid="B16-jcm-14-05932" ref-type="bibr">16</xref>], where the mean age was 40. Preoperative biopsy is not usually recommended for pigmented skin lesions in favor of excisional biopsy [<xref rid="B40-jcm-14-05932" ref-type="bibr">40</xref>]. However, in certain functional or aesthetically sensitive areas, a biopsy may be justified as a first-line procedure. In our review, several studies did not specify the performance of a biopsy and its modality, or mentioned the absence of one, which exposes the risk of unnecessary mutilating surgery, even in the presence of effective reconstruction techniques. EAU is now preferred to amputation in cases of in situ or minimally invasive melanoma, although there is no agreed Breslow threshold [<xref rid="B41-jcm-14-05932" ref-type="bibr">41</xref>,<xref rid="B42-jcm-14-05932" ref-type="bibr">42</xref>]. Most articles support this strategy, with a recurrence rate comparable to that of amputation [<xref rid="B16-jcm-14-05932" ref-type="bibr">16</xref>,<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B28-jcm-14-05932" ref-type="bibr">28</xref>,<xref rid="B43-jcm-14-05932" ref-type="bibr">43</xref>,<xref rid="B44-jcm-14-05932" ref-type="bibr">44</xref>].</p><p>Although some studies report more local recurrences after WLE, these often occur after the operation. However, it should be noted that this technique is primarily intended for less aggressive tumors without metastatic disease. Furthermore, anatomopathological control may be incomplete, as pointed out by Kimyai-Asaidi et al. [<xref rid="B45-jcm-14-05932" ref-type="bibr">45</xref>]. This also explains why sentinel lymph nodes are rarely used in these cases. Conversely, amputations are reserved for more advanced forms, with a higher metastatic potential.</p><p>There is no clear consensus on whether to perform immediate versus delayed reconstruction. Our literature review revealed a notable rate of local recurrence, with 67 out of 373 patients (approximately 18%) experiencing recurrence, most often requiring secondary amputation. When reported, the time to recurrence ranged from 5 months to 11 years. Unfortunately, the recurrence details were not consistently reported by the authors. The timing of recurrence was mentioned in only two studies: at 24 and 32 months in Goettmann et al. [<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>] and at 36 months in Rayatt et al. [<xref rid="B28-jcm-14-05932" ref-type="bibr">28</xref>]. Due to the heterogeneity in follow-up protocols and limited data, it was difficult to establish a clear correlation between surgical margin size and recurrence rate. However, the most extensive patient series, comprising 140 cases and reporting a recurrence rate of 16.4%, used low margins of 3 to 4 mm, including periosteum [<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>]. Reported cases of amputation following histological analysis of the resection specimen&#8212;including two in the literature&#8212;further support the rationale for delayed reconstruction, particularly in cases of invasive melanoma.</p><p>Two techniques have been proposed for margin assessment: intraoperative frozen section analysis, which is limited by the absence of specific immunostains (such as MART-1 and HMB-45), and the Mohs micrographic surgery technique, which can be performed either conventionally or in a staged manner. While Mohs is not recommended as a standard treatment for melanoma, it is employed in certain specific cases, particularly for lentigo maligna (Dubreuilh&#8217;s melanoma) [<xref rid="B6-jcm-14-05932" ref-type="bibr">6</xref>,<xref rid="B45-jcm-14-05932" ref-type="bibr">45</xref>,<xref rid="B46-jcm-14-05932" ref-type="bibr">46</xref>,<xref rid="B47-jcm-14-05932" ref-type="bibr">47</xref>]. It allows more precise histological control, but its accessibility remains limited, and its efficacy in this context is still debated. Most articles support this strategy, with a recurrence rate comparable to that of amputation [<xref rid="B16-jcm-14-05932" ref-type="bibr">16</xref>,<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B28-jcm-14-05932" ref-type="bibr">28</xref>,<xref rid="B42-jcm-14-05932" ref-type="bibr">42</xref>,<xref rid="B43-jcm-14-05932" ref-type="bibr">43</xref>]. Although some studies report a higher rate of local recurrence after wide local excision (WLE), it is important to note that this technique is generally reserved for less aggressive tumors without metastatic spread, which may influence recurrence patterns observed postoperatively.</p><p>Furthermore, anatomopathological control may be incomplete, as noted by Kimyai-Asaidi et al. [<xref rid="B45-jcm-14-05932" ref-type="bibr">45</xref>]. This also explains why sentinel lymph nodes are rarely used in these cases. Conversely, amputations are reserved for more advanced forms, with a higher metastatic potential.</p><p>Reconstruction approaches vary from total skin grafts, dermal matrices, to pedicled or free flaps [<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>,<xref rid="B22-jcm-14-05932" ref-type="bibr">22</xref>,<xref rid="B26-jcm-14-05932" ref-type="bibr">26</xref>]. The choice depends on the location, the functional importance of the finger or toe, the need for mechanical strength, or, on the contrary, aesthetic requirements. Free flaps or flaps with a temporary pedicle (flag flap type) may be too invasive for certain indications [<xref rid="B26-jcm-14-05932" ref-type="bibr">26</xref>]. In contrast, a graft combined with a dermal matrix is often a good compromise, especially for distal injuries with poor function [<xref rid="B28-jcm-14-05932" ref-type="bibr">28</xref>]. The inner arm is frequently used as a donor site, due to its hairless and discreet appearance [<xref rid="B48-jcm-14-05932" ref-type="bibr">48</xref>]. Dermal matrices provide post-operative comfort (reduced hypersensitivity) and allow coverage of exposed bone, enabling WLE with sub-periosteal resection or removal of the dorsal cortex of the last phalanx; however, they require additional operating time [<xref rid="B28-jcm-14-05932" ref-type="bibr">28</xref>,<xref rid="B33-jcm-14-05932" ref-type="bibr">33</xref>,<xref rid="B36-jcm-14-05932" ref-type="bibr">36</xref>]. For toe lesions, healing by secondary intention can also be considered, as it is often well tolerated when wearing protective footwear. These approaches remain eligible for outpatient surgery under locoregional anesthesia.</p><p>In our review, most of the reconstruction techniques [<xref rid="B13-jcm-14-05932" ref-type="bibr">13</xref>,<xref rid="B14-jcm-14-05932" ref-type="bibr">14</xref>,<xref rid="B15-jcm-14-05932" ref-type="bibr">15</xref>,<xref rid="B16-jcm-14-05932" ref-type="bibr">16</xref>,<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>,<xref rid="B18-jcm-14-05932" ref-type="bibr">18</xref>,<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>,<xref rid="B21-jcm-14-05932" ref-type="bibr">21</xref>,<xref rid="B23-jcm-14-05932" ref-type="bibr">23</xref>,<xref rid="B24-jcm-14-05932" ref-type="bibr">24</xref>,<xref rid="B27-jcm-14-05932" ref-type="bibr">27</xref>,<xref rid="B30-jcm-14-05932" ref-type="bibr">30</xref>,<xref rid="B31-jcm-14-05932" ref-type="bibr">31</xref>,<xref rid="B32-jcm-14-05932" ref-type="bibr">32</xref>] described were based on skin grafting, alone or in association with a matrix or local flap, which could be explained by the low logistical and organizational constraints of this procedure, the quality of the results it provides, its simplicity of execution and its independence in relation to the size of the recipient site. Although a single surgical procedure is the most ergonomic option, our review found a similar number of one-stage and two-stage procedures. The latter, sometimes due to the time required to incorporate the matrix, could be dispensed with by the advent of single-layer matrices. As for the functional and cosmetic results mentioned in our review, they were often judged as &#8220;good&#8221;, &#8220;acceptable&#8221;, or &#8220;satisfactory&#8221;, which unfortunately made interpretation difficult and subjective. Objective results, at best reported by the patient using validated scores, would enable an effective comparison of the different techniques for a given patient profile.</p><p>In our experience, reconstruction should be adapted as far as possible to the patient&#8217;s profile [<xref rid="B49-jcm-14-05932" ref-type="bibr">49</xref>,<xref rid="B50-jcm-14-05932" ref-type="bibr">50</xref>]. However, for upper limb localization, the combination of a dermal matrix and a total skin graft appears to us to be the most suitable technique, due to the high quality of the functional and cosmetic results. For lower limb injuries, the use of pedicled flaps, such as the intermetatarsal flap [<xref rid="B51-jcm-14-05932" ref-type="bibr">51</xref>], is our first-line option for reconstruction.</p><p>Neoadjuvant immunotherapy, already used for resectable stage III melanoma, could represent a turning point for localized forms such as SUM [<xref rid="B52-jcm-14-05932" ref-type="bibr">52</xref>,<xref rid="B53-jcm-14-05932" ref-type="bibr">53</xref>]. In the long term, it could make it possible to avoid certain amputations in favor of more conservative surgery such as WLE. However, these therapeutic options have not been widely studied, reflecting the persistent compartmentalization between medical and surgical disciplines.</p><p>The main limitations of our review relate to the lack of standardized functional evaluation of reconstructions, the heterogeneity of surgical techniques, and the absence of precise data on histological stage and recurrence. Overall study quality, as assessed using the Newcastle&#8211;Ottawa Scale and Joanna Briggs Institute checklists, was moderate: inclusion criteria and surgical protocols were generally well described, but sample sizes were small, techniques varied widely, and comparative analyses were scarce. Functional and aesthetic outcomes were assessed in a largely non-standardized manner, most often based on qualitative appraisal (surgeon judgment, patient-reported satisfaction or pain, or return to usual activities). Only Lee et al. [<xref rid="B24-jcm-14-05932" ref-type="bibr">24</xref>] employed validated PROMs (QuickDASH and Foot Function Index), reporting superior functional scores compared with amputation. This heterogeneity and lack of standardized tools limit comparability across studies and may overestimate the functional and aesthetic benefits of conservative approaches. Nevertheless, most series reported preserved function and satisfactory cosmetic outcomes after functional surgery. Future prospective multicenter studies should systematically use validated PROMs (QuickDASH, Foot Function Index, POSAS, SCAR-Q) and standardized definitions for local and distant recurrence to more accurately assess the oncological safety and long-term quality-of-life impact of reconstructive techniques, particularly in thin invasive lesions.</p></sec><sec sec-type="conclusions" id="sec5-jcm-14-05932"><title>5. Conclusions</title><p>The management of subungual melanoma is increasingly shifting towards WLE rather than amputation, particularly for in situ lesions or those with a low Breslow index. Across the included series, the recurrence rate is approximately 18%, with recurrence occurring between 5 months and 11 years, highlighting the need for long-term, systematic follow-up. Reconstructive techniques such as total skin grafts or dermal matrices can achieve satisfactory functional and aesthetic outcomes, yet objective, standardized evaluations are scarce, and adjuvant therapies are rarely reported. Future prospective, multicenter studies with standardized oncologic, functional, and quality-of-life endpoints are essential to optimize treatment strategies and ensure durable, patient-centered outcomes.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-jcm-14-05932"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.mdpi.com/article/10.3390/jcm14175932/s1">https://www.mdpi.com/article/10.3390/jcm14175932/s1</uri>, Table S1: Quality assessment of included studies according to the Newcastle&#8211;Ottawa Scale (NOS) or the Joanna Briggs Institute (JBI) checklist, depending on study design. &#8220;Instrumented validates&#8221; refers to the use of standardized, psychometrically validated tools.</p><supplementary-material id="jcm-14-05932-s001" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jcm-14-05932-s001.zip" position="float" orientation="portrait"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, O.C. and E.L.; methodology, E.L. and O.C.; software, L.C.; validation, O.C., F.B. and E.L.; formal analysis, E.L. and L.C.; investigation, L.C.; resources, E.L., T.B., F.B. and H.M.; data curation, L.C.; writing&#8212;original draft preparation, L.C.; writing&#8212;review and editing, E.L., O.C., T.B. and H.M. visualization, O.C., E.L. and F.B.; supervision, O.C., E.L. and T.B.; project administration, O.C., E.L., T.B. and H.M.; funding acquisition, E.L. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of University Institute for Locomotion and Sports (protocol code IRB00014528_2025_14 on 10 March 2025).</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The corresponding authors can provide the data upon request.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare that they have no conflicts of interest.</p></notes><glossary><title>Abbreviations</title><p>The following abbreviations are used in this manuscript:
<array orientation="portrait"><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">SUM</td><td align="left" valign="middle" rowspan="1" colspan="1">Subungual melanoma</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">WLE</td><td align="left" valign="middle" rowspan="1" colspan="1">Wide local excision (of nail apparatus)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">F</td><td align="left" valign="middle" rowspan="1" colspan="1">Finger</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">T</td><td align="left" valign="middle" rowspan="1" colspan="1">Toe</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FTSG</td><td align="left" valign="middle" rowspan="1" colspan="1">Full-thickness skin graft</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">STSG</td><td align="left" valign="middle" rowspan="1" colspan="1">Split-thickness skin graft</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NA</td><td align="left" valign="middle" rowspan="1" colspan="1">Non available</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Quick DASH</td><td align="left" valign="middle" rowspan="1" colspan="1">Score Quick Disabilities of the arm, shoulder, and hand (score ranges from 0, no obstacles, to 100, maximum obstacles)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MMWS</td><td align="left" valign="middle" rowspan="1" colspan="1">score ranging from 0, maximum disability, to 100, no disability</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Score AOFAS</td><td align="left" valign="middle" rowspan="1" colspan="1">The American Orthopedic Foot and Ankle Score (score ranging from 0, maximum disability, to 90, no disability)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FS</td><td align="left" valign="middle" rowspan="1" colspan="1">Functional surgery</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NOS</td><td align="left" valign="middle" rowspan="1" colspan="1">Newcastle&#8211;Ottawa Scale</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">JBI</td><td align="left" valign="middle" rowspan="1" colspan="1">Joanna Briggs Institute checklist</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FFI</td><td align="left" valign="middle" rowspan="1" colspan="1">Foot Function Index</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PROMs</td><td align="left" valign="middle" rowspan="1" colspan="1">Patient-reported outcome measures</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SCC</td><td align="left" valign="middle" rowspan="1" colspan="1">Squamous cell carcinoma</td></tr></tbody></array></p></glossary><ref-list><title>References</title><ref id="B1-jcm-14-05932"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>L.</given-names></name><name name-style="western"><surname>Chai</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name></person-group><article-title>Global trends in melanoma burden: A comprehensive analysis from the Global Burden of Disease Study, 1990&#8211;2021</article-title><source>J. Am. Acad. Dermatol.</source><year>2025</year><volume>92</volume><fpage>100</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.jaad.2024.09.035</pub-id><pub-id pub-id-type="pmid">39343306</pub-id></element-citation></ref><ref id="B2-jcm-14-05932"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Breslow</surname><given-names>A.</given-names></name></person-group><article-title>Tumor thickness in evaluating prognosis of cutaneous melanoma</article-title><source>Ann. Surg.</source><year>1978</year><volume>187</volume><fpage>440</fpage><pub-id pub-id-type="doi">10.1097/00000658-197804000-00020</pub-id><pub-id pub-id-type="pmcid">PMC1396376</pub-id><pub-id pub-id-type="pmid">646484</pub-id></element-citation></ref><ref id="B3-jcm-14-05932"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Breslow</surname><given-names>A.</given-names></name></person-group><article-title>Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma</article-title><source>Ann. Surg.</source><year>1970</year><volume>172</volume><fpage>902</fpage><lpage>908</lpage><pub-id pub-id-type="doi">10.1097/00000658-197011000-00017</pub-id><pub-id pub-id-type="pmid">5477666</pub-id><pub-id pub-id-type="pmcid">PMC1397358</pub-id></element-citation></ref><ref id="B4-jcm-14-05932"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>Y.J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>O.R.</given-names></name><name name-style="western"><surname>Park</surname><given-names>H.Y.</given-names></name><name name-style="western"><surname>Bahk</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y.B.</given-names></name></person-group><article-title>Whole-exome sequencing reveals differences between nail apparatus melanoma and acral melanoma</article-title><source>J. Am. Acad. Dermatol.</source><year>2018</year><volume>79</volume><fpage>559</fpage><lpage>561.e1</lpage><pub-id pub-id-type="doi">10.1016/j.jaad.2018.02.019</pub-id><pub-id pub-id-type="pmid">29438763</pub-id></element-citation></ref><ref id="B5-jcm-14-05932"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feibleman</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Stoll</surname><given-names>H.</given-names></name><name name-style="western"><surname>Maize</surname><given-names>J.C.</given-names></name></person-group><article-title>Melanomas of the palm, sole, and nailbed: A clinicopathologic study</article-title><source>Cancer</source><year>1980</year><volume>46</volume><fpage>2492</fpage><lpage>2504</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1097-0142(19801201)46:11&amp;#x0003c;2492::AID-CNCR2820461130&amp;#x0003e;3.0.CO;2-J</pub-id><pub-id pub-id-type="pmid">7438021</pub-id></element-citation></ref><ref id="B6-jcm-14-05932"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brodland</surname><given-names>D.G.</given-names></name></person-group><article-title>The treatment of nail apparatus melanoma with Mohs micrographic surgery</article-title><source>Dermatol. Surg.</source><year>2001</year><volume>27</volume><fpage>269</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">11277896</pub-id></element-citation></ref><ref id="B7-jcm-14-05932"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haneke</surname><given-names>E.</given-names></name></person-group><article-title>Ungual melanoma&#8212;controversies in diagnosis and treatment</article-title><source>Dermatol. Ther.</source><year>2012</year><volume>25</volume><fpage>510</fpage><lpage>524</lpage><pub-id pub-id-type="doi">10.1111/j.1529-8019.2012.01515.x</pub-id><pub-id pub-id-type="pmid">23210750</pub-id></element-citation></ref><ref id="B8-jcm-14-05932"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakamura</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ohara</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kishi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Teramoto</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sato</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fujisawa</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Fujimoto</surname><given-names>M.</given-names></name><name name-style="western"><surname>Otsuka</surname><given-names>F.</given-names></name><name name-style="western"><surname>Hayashi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Yamazaki</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Effects of non-amputative wide local excision on the local control and prognosis of in situ and invasive subungual melanoma</article-title><source>J. Dermatol.</source><year>2015</year><volume>42</volume><fpage>861</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1111/1346-8138.12923</pub-id><pub-id pub-id-type="pmid">25982364</pub-id></element-citation></ref><ref id="B9-jcm-14-05932"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cochran</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Buchanan</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Bueno</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Jr Neumeister</surname><given-names>M.W.</given-names></name></person-group><article-title>Subungual melanoma: A review of current treatment</article-title><source>Plast. Reconstr. Surg.</source><year>2014</year><volume>134</volume><fpage>259</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1097/PRS.0000000000000529</pub-id><pub-id pub-id-type="pmid">25068326</pub-id></element-citation></ref><ref id="B10-jcm-14-05932"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Temple-Oberle</surname><given-names>C.</given-names></name><name name-style="western"><surname>Nicholas</surname><given-names>C.</given-names></name><name name-style="western"><surname>Rojas-Garcia</surname><given-names>P.</given-names></name></person-group><article-title>Current Controversies in Melanoma Treatment</article-title><source>Plast. Reconstr. Surg.</source><year>2023</year><volume>151</volume><fpage>495e</fpage><lpage>505e</lpage><pub-id pub-id-type="doi">10.1097/PRS.0000000000009936</pub-id><pub-id pub-id-type="pmid">36821575</pub-id></element-citation></ref><ref id="B11-jcm-14-05932"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baran</surname><given-names>R.G.-B.S.M.I.</given-names></name><name name-style="western"><surname>Robert</surname><given-names>C.</given-names></name></person-group><article-title>Traitement du m&#233;lanome de l&#8217;appareil ungu&#233;al</article-title><source>Ann. Dermatol. V&#233;n&#233;r&#233;ologie</source><year>2021</year><volume>1</volume><fpage>128</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/j.fander.2020.07.010</pub-id></element-citation></ref><ref id="B12-jcm-14-05932"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hovgaard</surname><given-names>C.</given-names></name><name name-style="western"><surname>Angermann</surname><given-names>P.</given-names></name><name name-style="western"><surname>Hovgaard</surname><given-names>D.</given-names></name></person-group><article-title>The social and economic consequences of finger amputations</article-title><source>Acta. Orthop. Scand.</source><year>1994</year><volume>65</volume><fpage>347</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.3109/17453679408995468</pub-id><pub-id pub-id-type="pmid">8042493</pub-id></element-citation></ref><ref id="B13-jcm-14-05932"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poumellec</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Camuzard</surname><given-names>O.</given-names></name><name name-style="western"><surname>Dumontier</surname><given-names>C.</given-names></name></person-group><article-title>Hook nail deformity</article-title><source>Hand. Surg. Rehabil.</source><year>2024</year><volume>43s</volume><fpage>101649</fpage><pub-id pub-id-type="doi">10.1016/j.hansur.2024.101649</pub-id><pub-id pub-id-type="pmid">38280632</pub-id></element-citation></ref><ref id="B14-jcm-14-05932"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Page</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Bossuyt</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Boutron</surname><given-names>I.</given-names></name><name name-style="western"><surname>Hoffmann</surname><given-names>T.C.</given-names></name><name name-style="western"><surname>Mulrow</surname><given-names>C.D.</given-names></name><name name-style="western"><surname>Shamseer</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tetzlaff</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Akl</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Brennan</surname><given-names>S.E.</given-names></name><etal/></person-group><article-title>The PRISMA 2020 statement: An updated guideline for reporting systematic reviews</article-title><source>BMJ</source><year>2021</year><volume>372</volume><fpage>n71</fpage><pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id><pub-id pub-id-type="pmid">33782057</pub-id><pub-id pub-id-type="pmcid">PMC8005924</pub-id></element-citation></ref><ref id="B15-jcm-14-05932"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anda-Ju&#225;rez</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Mart&#237;nez-Velasco</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Fonte-&#193;valos</surname><given-names>V.</given-names></name><name name-style="western"><surname>Toussaint-Caire</surname><given-names>S.</given-names></name><name name-style="western"><surname>Dom&#237;nguez-Cherit</surname><given-names>J.</given-names></name></person-group><article-title>Conservative surgical management of in situ subungual melanoma: Long-term follow-up</article-title><source>An. Bras. Dermatol.</source><year>2016</year><volume>91</volume><fpage>846</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1590/abd1806-4841.201645100</pub-id><pub-id pub-id-type="pmid">28099619</pub-id><pub-id pub-id-type="pmcid">PMC5193208</pub-id></element-citation></ref><ref id="B16-jcm-14-05932"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lazar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Abimelec</surname><given-names>P.</given-names></name><name name-style="western"><surname>Dumontier</surname><given-names>C.</given-names></name></person-group><article-title>Full thickness skin graft for nail unit reconstruction</article-title><source>J. Hand. Surg. Br.</source><year>2005</year><volume>30</volume><fpage>194</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1016/J.JHSB.2004.11.006</pub-id><pub-id pub-id-type="pmid">15757774</pub-id></element-citation></ref><ref id="B17-jcm-14-05932"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Puhaindran</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Cordeiro</surname><given-names>P.G.</given-names></name><name name-style="western"><surname>Disa</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Mehrara</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Athanasian</surname><given-names>E.A.</given-names></name></person-group><article-title>Full-thickness skin graft after nail complex resection for malignant tumors</article-title><source>Tech. Hand. Up. Extrem. Surg.</source><year>2011</year><volume>15</volume><fpage>84</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1097/BTH.0b013e3181ee7e00</pub-id><pub-id pub-id-type="pmid">21606778</pub-id></element-citation></ref><ref id="B18-jcm-14-05932"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flores-Terry</surname><given-names>M.</given-names></name><name name-style="western"><surname>Romero-Aguilera</surname><given-names>G.</given-names></name><name name-style="western"><surname>Mendoza</surname><given-names>C.</given-names></name><name name-style="western"><surname>Franco</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cortina</surname><given-names>P.</given-names></name><name name-style="western"><surname>Garcia-Arpa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gonzalez-Ruiz</surname><given-names>L.</given-names></name><name name-style="western"><surname>Garrido</surname><given-names>J.A.</given-names></name></person-group><article-title>Functional Surgery for Malignant Subungual Tumors: A Case Series and Literature Review</article-title><source>Actas Dermosifiliogr. (Engl. Ed.)</source><year>2018</year><volume>109</volume><fpage>712</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.1016/j.ad.2018.05.002</pub-id><pub-id pub-id-type="pmid">30293553</pub-id></element-citation></ref><ref id="B19-jcm-14-05932"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moehrle</surname><given-names>M.</given-names></name><name name-style="western"><surname>Metzger</surname><given-names>S.</given-names></name><name name-style="western"><surname>Schippert</surname><given-names>W.</given-names></name><name name-style="western"><surname>Garbe</surname><given-names>C.</given-names></name><name name-style="western"><surname>Rassner</surname><given-names>G.</given-names></name><name name-style="western"><surname>Breuninger</surname><given-names>H.</given-names></name></person-group><article-title>&#8220;Functional&#8221; surgery in subungual melanoma</article-title><source>Dermatol. Surg.</source><year>2003</year><volume>29</volume><fpage>366</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">12656815</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1524-4725.2003.29087.x</pub-id></element-citation></ref><ref id="B20-jcm-14-05932"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goettmann</surname><given-names>S.</given-names></name><name name-style="western"><surname>Moulonguet</surname><given-names>I.</given-names></name><name name-style="western"><surname>Zaraa</surname><given-names>I.</given-names></name></person-group><article-title>In situ nail unit melanoma: Epidemiological and clinic-pathologic features with conservative treatment and long-term follow-up</article-title><source>J. Eur. Acad. Dermatol. Venereol.</source><year>2018</year><volume>32</volume><fpage>2300</fpage><lpage>2306</lpage><pub-id pub-id-type="doi">10.1111/jdv.15124</pub-id><pub-id pub-id-type="pmid">29894582</pub-id></element-citation></ref><ref id="B21-jcm-14-05932"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sinno</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>S.</given-names></name><name name-style="western"><surname>Billig</surname><given-names>J.</given-names></name><name name-style="western"><surname>Shapiro</surname><given-names>R.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>M.</given-names></name></person-group><article-title>Primary melanoma of the hand: An algorithmic approach to surgical management</article-title><source>J. Plast. Surg. Hand. Surg.</source><year>2015</year><volume>49</volume><fpage>339</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.3109/2000656X.2015.1053396</pub-id><pub-id pub-id-type="pmid">26051472</pub-id></element-citation></ref><ref id="B22-jcm-14-05932"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oh</surname><given-names>B.H.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Roh</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Nam</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>K.Y.</given-names></name></person-group><article-title>Risk of recurrence of nail unit melanoma after functional surgery versus amputation</article-title><source>J. Am. Acad. Dermatol.</source><year>2023</year><volume>88</volume><fpage>1017</fpage><lpage>1023</lpage><pub-id pub-id-type="doi">10.1016/j.jaad.2022.12.039</pub-id><pub-id pub-id-type="pmid">36642330</pub-id></element-citation></ref><ref id="B23-jcm-14-05932"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wollina</surname><given-names>U.</given-names></name><name name-style="western"><surname>Tempel</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hansel</surname><given-names>G.</given-names></name></person-group><article-title>Subungual melanoma: A single center series from Dresden</article-title><source>Dermatol. Ther.</source><year>2019</year><volume>32</volume><fpage>e13032</fpage><pub-id pub-id-type="doi">10.1111/dth.13032</pub-id><pub-id pub-id-type="pmid">31344289</pub-id></element-citation></ref><ref id="B24-jcm-14-05932"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>K.T.</given-names></name><name name-style="western"><surname>Park</surname><given-names>B.Y.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Jang</surname><given-names>K.T.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>D.Y.</given-names></name><name name-style="western"><surname>Mun</surname><given-names>G.H.</given-names></name></person-group><article-title>Superthin SCIP Flap for Reconstruction of Subungual Melanoma: Aesthetic Functional Surgery</article-title><source>Plast. Reconstr. Surg.</source><year>2017</year><volume>140</volume><fpage>1278</fpage><lpage>1289</lpage><pub-id pub-id-type="doi">10.1097/PRS.0000000000003881</pub-id><pub-id pub-id-type="pmid">28820834</pub-id></element-citation></ref><ref id="B25-jcm-14-05932"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sureda</surname><given-names>N.</given-names></name><name name-style="western"><surname>Phan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Poulalhon</surname><given-names>N.</given-names></name><name name-style="western"><surname>Balme</surname><given-names>B.</given-names></name><name name-style="western"><surname>Dalle</surname><given-names>S.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>L.</given-names></name></person-group><article-title>Conservative surgical management of subungual (matrix derived) melanoma: Report of seven cases and literature review</article-title><source>Br. J. Dermatol.</source><year>2011</year><volume>165</volume><fpage>852</fpage><lpage>858</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2133.2011.10477.x</pub-id><pub-id pub-id-type="pmid">21812768</pub-id></element-citation></ref><ref id="B26-jcm-14-05932"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neczyporenko</surname><given-names>F.</given-names></name><name name-style="western"><surname>Andr&#233;</surname><given-names>J.</given-names></name><name name-style="western"><surname>Torosian</surname><given-names>K.</given-names></name><name name-style="western"><surname>Theunis</surname><given-names>A.</given-names></name><name name-style="western"><surname>Richert</surname><given-names>B.</given-names></name></person-group><article-title>Management of in situ melanoma of the nail apparatus with functional surgery: Report of 11 cases and review of the literature</article-title><source>J. Eur. Acad. Dermatol. Venereol.</source><year>2014</year><volume>28</volume><fpage>550</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1111/jdv.12131</pub-id><pub-id pub-id-type="pmid">23480439</pub-id></element-citation></ref><ref id="B27-jcm-14-05932"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Terushkin</surname><given-names>V.</given-names></name><name name-style="western"><surname>Brodland</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Sharon</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Zitelli</surname><given-names>J.A.</given-names></name></person-group><article-title>Digit-Sparing Mohs Surgery for Melanoma</article-title><source>Dermatol. Surg.</source><year>2016</year><volume>42</volume><fpage>83</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1097/DSS.0000000000000587</pub-id><pub-id pub-id-type="pmid">26655701</pub-id></element-citation></ref><ref id="B28-jcm-14-05932"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rayatt</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Dancey</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Davison</surname><given-names>P.M.</given-names></name></person-group><article-title>Thumb subungual melanoma: Is amputation necessary?</article-title><source>J. Plast. Reconstr. Aesthet. Surg.</source><year>2007</year><volume>60</volume><fpage>635</fpage><lpage>638</lpage><pub-id pub-id-type="doi">10.1016/j.bjps.2006.10.014</pub-id><pub-id pub-id-type="pmid">17485051</pub-id></element-citation></ref><ref id="B29-jcm-14-05932"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Imakado</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sato</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hamada</surname><given-names>K.</given-names></name></person-group><article-title>Two cases of subungual melanoma in situ</article-title><source>J. Dermatol.</source><year>2008</year><volume>35</volume><fpage>754</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1111/j.1346-8138.2008.00557.x</pub-id><pub-id pub-id-type="pmid">19120774</pub-id></element-citation></ref><ref id="B30-jcm-14-05932"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Hsieh</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Chou</surname><given-names>P.R.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>S.H.</given-names></name></person-group><article-title>Reconstruction for Defects of Total Nail Bed and Germinal Matrix Loss with Acellular Dermal Matrix Coverage and Subsequently Skin Graft</article-title><source>Medicina</source><year>2020</year><volume>56</volume><elocation-id>17</elocation-id><pub-id pub-id-type="doi">10.3390/medicina56010017</pub-id><pub-id pub-id-type="pmid">31947851</pub-id><pub-id pub-id-type="pmcid">PMC7023242</pub-id></element-citation></ref><ref id="B31-jcm-14-05932"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crisan</surname><given-names>D.</given-names></name><name name-style="western"><surname>G&#252;lke</surname><given-names>J.</given-names></name><name name-style="western"><surname>Janetzko</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kastler</surname><given-names>S.</given-names></name><name name-style="western"><surname>Treiber</surname><given-names>N.</given-names></name><name name-style="western"><surname>Scharffetter-Kochanek</surname><given-names>K.</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>L.A.</given-names></name></person-group><article-title>Digit preserving surgery of subungual melanoma: A case series using vacuum assisted closure and full-thickness skin grafting</article-title><source>J. Eur. Acad. Dermatol. Venereol.</source><year>2017</year><volume>31</volume><fpage>e537</fpage><lpage>e538</lpage><pub-id pub-id-type="doi">10.1111/jdv.14400</pub-id><pub-id pub-id-type="pmid">28609554</pub-id></element-citation></ref><ref id="B32-jcm-14-05932"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>High</surname><given-names>W.A.</given-names></name><name name-style="western"><surname>Quirey</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Guill&#233;n</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Mun&#245;z</surname><given-names>G.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>R.S.</given-names></name></person-group><article-title>Presentation, histopathologic findings, and clinical outcomes in 7 cases of melanoma in situ of the nail unit</article-title><source>Arch. Dermatol.</source><year>2004</year><volume>140</volume><fpage>1102</fpage><lpage>1106</lpage><pub-id pub-id-type="doi">10.1001/archderm.140.9.1102</pub-id><pub-id pub-id-type="pmid">15381551</pub-id></element-citation></ref><ref id="B33-jcm-14-05932"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chow</surname><given-names>W.T.</given-names></name><name name-style="western"><surname>Bhat</surname><given-names>W.</given-names></name><name name-style="western"><surname>Magdub</surname><given-names>S.</given-names></name><name name-style="western"><surname>Orlando</surname><given-names>A.</given-names></name></person-group><article-title>In situ subungual melanoma: Digit salvaging clearance</article-title><source>J. Plast. Reconstr. Aesthet. Surg.</source><year>2013</year><volume>66</volume><fpage>274</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1016/j.bjps.2012.06.022</pub-id><pub-id pub-id-type="pmid">22809529</pub-id></element-citation></ref><ref id="B34-jcm-14-05932"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duarte</surname><given-names>A.F.</given-names></name><name name-style="western"><surname>Correia</surname><given-names>O.</given-names></name><name name-style="western"><surname>Barros</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Azevedo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Haneke</surname><given-names>E.</given-names></name></person-group><article-title>Nail matrix melanoma in situ: Conservative surgical management</article-title><source>Dermatology</source><year>2010</year><volume>220</volume><fpage>173</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1159/000266038</pub-id><pub-id pub-id-type="pmid">20016126</pub-id></element-citation></ref><ref id="B35-jcm-14-05932"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smock</surname><given-names>E.D.</given-names></name><name name-style="western"><surname>Barabas</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Geh</surname><given-names>J.L.</given-names></name></person-group><article-title>Reconstruction of a thumb defect with Integra following wide local excision of a subungual melanoma</article-title><source>J. Plast. Reconstr. Aesthet. Surg.</source><year>2010</year><volume>63</volume><fpage>e36</fpage><lpage>e37</lpage><pub-id pub-id-type="doi">10.1016/j.bjps.2009.05.010</pub-id><pub-id pub-id-type="pmid">19617018</pub-id></element-citation></ref><ref id="B36-jcm-14-05932"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bjedov</surname><given-names>S.</given-names></name><name name-style="western"><surname>Je&#382;i&#263;</surname><given-names>I.</given-names></name><name name-style="western"><surname>Buli&#263;</surname><given-names>K.</given-names></name></person-group><article-title>Reconstruction of a Thumb Defect Following Subungual Melanoma Resection Using Foucher&#8217;s Flap</article-title><source>Acta. Dermatovenerol. Croat.</source><year>2019</year><volume>27</volume><fpage>51</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">31032796</pub-id></element-citation></ref><ref id="B37-jcm-14-05932"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Motta</surname><given-names>A.</given-names></name><name name-style="western"><surname>L&#243;pez</surname><given-names>C.</given-names></name><name name-style="western"><surname>Acosta</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pe&#241;aranda</surname><given-names>C.</given-names></name></person-group><article-title>Subungual melanoma in situ in a Hispanic girl treated with functional resection and reconstruction with onychocutaneous toe free flap</article-title><source>Arch. Dermatol.</source><year>2007</year><volume>143</volume><fpage>1600</fpage><lpage>1602</lpage><pub-id pub-id-type="doi">10.1001/archderm.143.12.1600</pub-id><pub-id pub-id-type="pmid">18087026</pub-id></element-citation></ref><ref id="B38-jcm-14-05932"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hayashi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Uhara</surname><given-names>H.</given-names></name><name name-style="western"><surname>Koga</surname><given-names>H.</given-names></name><name name-style="western"><surname>Okuyama</surname><given-names>R.</given-names></name><name name-style="western"><surname>Saida</surname><given-names>T.</given-names></name></person-group><article-title>Surgical treatment of nail apparatus melanoma in situ: The use of artificial dermis in reconstruction</article-title><source>Dermatol. Surg.</source><year>2012</year><volume>38</volume><fpage>692</fpage><lpage>694</lpage><pub-id pub-id-type="doi">10.1111/j.1524-4725.2011.02217.x</pub-id><pub-id pub-id-type="pmid">22092771</pub-id></element-citation></ref><ref id="B39-jcm-14-05932"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boyer</surname><given-names>A.</given-names></name></person-group><article-title>A fungus hematode du petit doigt</article-title><source>Gaz. Med.</source><year>1834</year><fpage>212</fpage></element-citation></ref><ref id="B40-jcm-14-05932"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levit</surname><given-names>E.K.</given-names></name><name name-style="western"><surname>Kagen</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Scher</surname><given-names>R.K.</given-names></name><name name-style="western"><surname>Grossman</surname><given-names>M.</given-names></name><name name-style="western"><surname>Altman</surname><given-names>E.</given-names></name></person-group><article-title>The ABC rule for clinical detection of subungual melanoma</article-title><source>J. Am. Acad. Dermatol.</source><year>2000</year><volume>42</volume><issue-part>Pt 1</issue-part><fpage>269</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1016/S0190-9622(00)90137-3</pub-id><pub-id pub-id-type="pmid">10642684</pub-id></element-citation></ref><ref id="B41-jcm-14-05932"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tran</surname><given-names>K.T.</given-names></name><name name-style="western"><surname>Wright</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Cockerell</surname><given-names>C.J.</given-names></name></person-group><article-title>Biopsy of the pigmented lesion&#8212;When and how</article-title><source>J. Am. Acad. Dermatol.</source><year>2008</year><volume>59</volume><fpage>852</fpage><lpage>871</lpage><pub-id pub-id-type="doi">10.1016/j.jaad.2008.05.027</pub-id><pub-id pub-id-type="pmid">18762353</pub-id></element-citation></ref><ref id="B42-jcm-14-05932"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guillot</surname><given-names>B.</given-names></name><name name-style="western"><surname>Dalac</surname><given-names>S.</given-names></name><name name-style="western"><surname>Denis</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Dupuy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Emile</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>De La Fouchardiere</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hindie</surname><given-names>E.</given-names></name><name name-style="western"><surname>Jouary</surname><given-names>T.</given-names></name><name name-style="western"><surname>Lassau</surname><given-names>N.</given-names></name><name name-style="western"><surname>Mirabel</surname><given-names>X.</given-names></name></person-group><article-title>French updated recommendations in Stage I to III melanoma treatment and management</article-title><source>J. Eur. Acad. Dermatol. Venereol.</source><year>2017</year><volume>31</volume><fpage>594</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1111/jdv.14064</pub-id><pub-id pub-id-type="pmid">28120528</pub-id></element-citation></ref><ref id="B43-jcm-14-05932"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>K.G.</given-names></name><name name-style="western"><surname>Blessing</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kernohan</surname><given-names>N.M.</given-names></name></person-group><article-title>Surgical aspects of subungual malignant melanomas. The Scottish Melanoma Group</article-title><source>Ann. Surg.</source><year>1992</year><volume>216</volume><fpage>692</fpage><lpage>695</lpage><pub-id pub-id-type="doi">10.1097/00000658-199212000-00012</pub-id><pub-id pub-id-type="pmid">1466623</pub-id><pub-id pub-id-type="pmcid">PMC1242717</pub-id></element-citation></ref><ref id="B44-jcm-14-05932"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jo</surname><given-names>G.</given-names></name><name name-style="western"><surname>Cho</surname><given-names>S.I.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mun</surname><given-names>J.H.</given-names></name></person-group><article-title>Functional surgery versus amputation for in situ or minimally invasive nail melanoma: A meta-analysis</article-title><source>J. Am. Acad. Dermatol.</source><year>2019</year><volume>81</volume><fpage>917</fpage><lpage>922</lpage><pub-id pub-id-type="doi">10.1016/j.jaad.2019.06.012</pub-id><pub-id pub-id-type="pmid">31202868</pub-id></element-citation></ref><ref id="B45-jcm-14-05932"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kimyai-Asadi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Katz</surname><given-names>T.</given-names></name><name name-style="western"><surname>Goldberg</surname><given-names>L.H.</given-names></name><name name-style="western"><surname>Ayala</surname><given-names>G.B.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.Q.</given-names></name><name name-style="western"><surname>Vujevich</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Jih</surname><given-names>M.H.</given-names></name></person-group><article-title>Margin involvement after the excision of melanoma in situ: The need for complete en face examination of the surgical margins</article-title><source>Dermatol. Surg.</source><year>2007</year><volume>33</volume><fpage>1434</fpage><lpage>1439</lpage><page-range>1434&#8211;1439; discussion 9&#8211;41</page-range><pub-id pub-id-type="doi">10.1097/00042728-200712000-00004</pub-id><pub-id pub-id-type="pmid">18076608</pub-id></element-citation></ref><ref id="B46-jcm-14-05932"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hewitt</surname><given-names>B.B.</given-names></name><name name-style="western"><surname>Bradley</surname><given-names>E.</given-names></name><name name-style="western"><surname>Berger</surname><given-names>A.C.</given-names></name></person-group><article-title>Margins of Melanoma Excision and Modifications to Standards</article-title><source>Surg. Oncol. Clin. N. Am.</source><year>2020</year><volume>29</volume><fpage>339</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1016/j.soc.2020.02.002</pub-id><pub-id pub-id-type="pmid">32482312</pub-id></element-citation></ref><ref id="B47-jcm-14-05932"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Swetter</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Tsao</surname><given-names>H.</given-names></name><name name-style="western"><surname>Bichakjian</surname><given-names>C.K.</given-names></name><name name-style="western"><surname>Curiel-Lewandrowski</surname><given-names>C.</given-names></name><name name-style="western"><surname>Elder</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Gershenwald</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Guild</surname><given-names>V.</given-names></name><name name-style="western"><surname>Grant-Kels</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Halpern</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>T.M.</given-names></name><etal/></person-group><article-title>Guidelines of care for the management of primary cutaneous melanoma</article-title><source>J. Am. Acad. Dermatol.</source><year>2019</year><volume>80</volume><fpage>208</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1016/j.jaad.2018.08.055</pub-id><pub-id pub-id-type="pmid">30392755</pub-id></element-citation></ref><ref id="B48-jcm-14-05932"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Majchrzak</surname><given-names>A.</given-names></name><name name-style="western"><surname>Paleu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Guena</surname><given-names>B.</given-names></name><name name-style="western"><surname>Chaput</surname><given-names>B.</given-names></name><name name-style="western"><surname>Camuzard</surname><given-names>O.</given-names></name><name name-style="western"><surname>Lupon</surname><given-names>E.</given-names></name></person-group><article-title>Posterior arm perforator flap for coverage of the scapular area</article-title><source>Ann. Chir. Plast. Esthet.</source><year>2025</year><volume>70</volume><fpage>63</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.anplas.2024.09.003</pub-id><pub-id pub-id-type="pmid">39448340</pub-id></element-citation></ref><ref id="B49-jcm-14-05932"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meresse</surname><given-names>T.</given-names></name><name name-style="western"><surname>Lupon</surname><given-names>E.</given-names></name><name name-style="western"><surname>Berkane</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Classe</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Camuzard</surname><given-names>O.</given-names></name><name name-style="western"><surname>Gangloff</surname><given-names>D.</given-names></name></person-group><article-title>Oncologic plastic surgery: An essential activity to develop in France</article-title><source>Ann. Chir. Plast. Esthet.</source><year>2023</year><volume>68</volume><fpage>286</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1016/j.anplas.2023.02.002</pub-id><pub-id pub-id-type="pmid">36967308</pub-id></element-citation></ref><ref id="B50-jcm-14-05932"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Albadia</surname><given-names>R.</given-names></name><name name-style="western"><surname>Rousset</surname><given-names>P.</given-names></name><name name-style="western"><surname>Massalou</surname><given-names>D.</given-names></name><name name-style="western"><surname>Camuzard</surname><given-names>O.</given-names></name><name name-style="western"><surname>Montaudi&#233;</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lupon</surname><given-names>E.</given-names></name></person-group><article-title>Management of a large abdominal dermatofibrosarcoma protuberans requiring a life-threatening excision: A case report</article-title><source>Int. J. Surg. Case. Rep.</source><year>2025</year><volume>133</volume><fpage>111579</fpage><pub-id pub-id-type="doi">10.1016/j.ijscr.2025.111579</pub-id><pub-id pub-id-type="pmid">40582063</pub-id><pub-id pub-id-type="pmcid">PMC12266473</pub-id></element-citation></ref><ref id="B51-jcm-14-05932"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saboye</surname><given-names>M.</given-names></name><name name-style="western"><surname>Majchrzak</surname><given-names>A.</given-names></name><name name-style="western"><surname>d&#8217;Andr&#233;a</surname><given-names>G.</given-names></name><name name-style="western"><surname>Bronsard</surname><given-names>N.</given-names></name><name name-style="western"><surname>Camuzard</surname><given-names>O.</given-names></name><name name-style="western"><surname>Lupon</surname><given-names>E.</given-names></name></person-group><article-title>The First Dorsal Metatarsal Artery Perforator Flap: A Description and Anatomical Study</article-title><source>J. Clin. Med.</source><year>2025</year><volume>14</volume><elocation-id>4136</elocation-id><pub-id pub-id-type="doi">10.3390/jcm14124136</pub-id><pub-id pub-id-type="pmid">40565881</pub-id><pub-id pub-id-type="pmcid">PMC12194064</pub-id></element-citation></ref><ref id="B52-jcm-14-05932"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blank</surname><given-names>C.U.</given-names></name><name name-style="western"><surname>Lucas</surname><given-names>M.W.</given-names></name><name name-style="western"><surname>Scolyer</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>van de Wiel</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Menzies</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Lopez-Yurda</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hoeijmakers</surname><given-names>L.L.</given-names></name><name name-style="western"><surname>Saw</surname><given-names>R.P.</given-names></name><name name-style="western"><surname>Lijnsvelt</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Maher</surname><given-names>N.G.</given-names></name><etal/></person-group><article-title>Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma</article-title><source>N. Engl. J. Med.</source><year>2024</year><volume>391</volume><fpage>1696</fpage><lpage>1708</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2402604</pub-id><pub-id pub-id-type="pmid">38828984</pub-id></element-citation></ref><ref id="B53-jcm-14-05932"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chouquet</surname><given-names>L.</given-names></name><name name-style="western"><surname>Poissonnet</surname><given-names>G.</given-names></name><name name-style="western"><surname>Picard</surname><given-names>A.</given-names></name><name name-style="western"><surname>Camuzard</surname><given-names>O.</given-names></name><name name-style="western"><surname>Gangloff</surname><given-names>D.</given-names></name><name name-style="western"><surname>Lupon</surname><given-names>E.</given-names></name></person-group><article-title>What&#8217;s new in oncologic plastic surgery in 2025?</article-title><source>Ann. Chir. Plast. Esthet.</source><year>2025</year><volume>5</volume><fpage>S0294</fpage><lpage>S1260</lpage><pub-id pub-id-type="doi">10.1016/j.anplas.2025.06.016</pub-id><pub-id pub-id-type="pmid">40619322</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="jcm-14-05932-f001" orientation="portrait"><label>Figure 1</label><caption><p>Flowchart.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-14-05932-g001.jpg"/></fig><table-wrap position="float" id="jcm-14-05932-t001" orientation="portrait"><object-id pub-id-type="pii">jcm-14-05932-t001_Table 1</object-id><label>Table 1</label><caption><p>Characteristics of included studies on reconstruction after wide local excision for subungual melanoma.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type of Article <break/><break/>Number of <break/>Patients<break/>Distribution<break/><break/>Mean Age (Years) (Range)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Localization<break/><break/>F (Finger)<break/>T (Toe)<break/>(n)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Local <break/>Extension</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Presence of <break/>Previous Biopsy<break/><break/>Margins from Nail Apparatus</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Strategy of <break/>Reconstruction<break/>Surgical Management</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Side Effects, <break/>Complications</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Complementary <break/>Treatment</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Results</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Follow Up<break/>Mean (Range)</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anda-Juarez et al., An Bras Dermatol, 2016 [<xref rid="B15-jcm-14-05932" ref-type="bibr">15</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective <break/><break/>15 patients (9F, 6M)<break/><break/>31 (4&#8211;66)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Right hand: F2 (2), F4 (2), F5 (1)<break/>Left hand:<break/>F1 (1), F5 (3)<break/>Right foot (5):<break/>T1 (5)<break/>Left foot (1): <break/>T1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SUM in situ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 mm <break/><break/>Supra periosteum resection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FTSG (14)<break/><break/>Banner flap (1 patient)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No recurrence <break/><break/>Inclusion cysts (4)<break/>Spicules (6)<break/>Hypersensitivity (4)<break/>Moderate chronic pain (1)<break/>Hyperpigmentation of the skin graft (9)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Functional and cosmetic outcomes were good in all of them </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55 months (12&#8211;98)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lazar et al., HandSurg Br, 2005 [<xref rid="B16-jcm-14-05932" ref-type="bibr">16</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective<break/><break/>13 patients (8F, 5M)<break/><break/>10 patients with SUM (7F, 3M)<break/><break/>40 (NA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Right hand <break/>F1 (3), F3 (1), F5 (1)<break/><break/>Left hand:<break/>F1 (2), F5(3)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SUM in situ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 mm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immediate FTSG harvested from same forearm (9)<break/>Delayed FTSG harvested from same forearm (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Temporary finger exclusion (1 case)<break/>Epidermal cyst (5 cases)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sensitivity: Weber 4&#8211;6 mm (7), NA (1)<break/>Normal function (4), Slightly limited function (5), NA (1)<break/>Cosmetic outcome: Satisfied or normal (9), NA (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48 months (6&#8211;84)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Puhaindran et al., Tech Hand Up Extrem Surg, 2011 [<xref rid="B17-jcm-14-05932" ref-type="bibr">17</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective<break/><break/>10 patients <break/>(4F, 6 M)<break/><break/>6 patients with a SUM<break/><break/>MA 52 (24&#8211;80)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SUM in situ, &lt;2 cm diameter</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 mm to nail fold</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immediate FTSG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Positive margin (1), treated by PID Disarticulation <break/><break/>Secondary surgery: <break/>Epidermal inclusion cyst (1)<break/>Nail remnant (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acceptable appearance for all patients (assessed by 2 surgeons) <break/><break/>Patients satisfied (6)<break/><break/>Unrestricted use of the hand (6)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35 months (8&#8211;72)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flores-Terry et al., Actas Dermosifiliogr, 2018 [<xref rid="B18-jcm-14-05932" ref-type="bibr">18</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective<break/><break/>11 patients<break/><break/>7 patients with SUM (4F, 3M)<break/><break/>5 patients (3F, 2M)<break/>treated by WLE <break/><break/>61 (45&#8211;81)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Right hand:<break/>F2 (1)<break/>F3 (1)<break/><break/>Left hand<break/>F1 (1)<break/>F2 (1)<break/><break/>Right foot:<break/>T1 (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SUM in situ (4)<break/><break/>or Sum with Breslow &lt; 1 mm (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Previous biopsy<break/>5 mm <break/>Supra periosteum resection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Circumferential advancement flap<break/>and<break/>Immediate FTSG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No recurrency (5)<break/><break/>Wound infection (2)<break/>subungual spicules (1), moderate stiffness of DIP of one finger (1), hypersensitivity to cold (2), hypersensitivity to mild trauma (4)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patients were satisfied with the procedure and the results obtained (5)<break/><break/>Satisfaction was good, and the impact on quality of life was minimal (5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39 months (12&#8211;96)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moehrle et al., Dermatol Surg, 2003 [<xref rid="B19-jcm-14-05932" ref-type="bibr">19</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective<break/><break/>62 patients with SUM (25H, 37F)<break/><break/>31 treated by WLE (11H, 20F)<break/><break/>MA 61 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F1,2,3,4,5 (20)<break/>T1,2,3,4,5 (11)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SUM in situ <break/><break/><break/>Invasive SUM <break/>Breslow &lt; 1 mm<break/>(6)<break/>Breslow 1 to 2 mm<break/>(8)<break/>Breslow 2 to 4 mm<break/>(6)<break/>Breslow &gt; 4 mm<break/>(4)<break/>NA: (7)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 mm<break/>WLE with safety margin without bone resection (3)<break/>WLE with safety margin with resection of the distal part of the distal phalanx (28)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FTSG with pulpal advancement flap<break/>Single stage (1)<break/>Several stages (30)<break/>Unspecified reconstruction after definitive three-dimensional histology</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Recurrences (20 patients)<break/>Local recurrence (2)<break/>In transit recurrence (1)<break/>Lymph node metastasis (7)<break/>Distant metastasis (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Function and cosmesis of the involved finger or toe &#8220;preserved&#8221;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">54 months (NA)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Goettmann et al., J Eur Acad Dermatol Venereol, 2018 [<xref rid="B20-jcm-14-05932" ref-type="bibr">20</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective<break/><break/>63 patients (44F, 19M)<break/><break/>58 treated by WLE <break/><break/>51 (NA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F1 (24)<break/>F2,3,4,5 (23)<break/>T1 (10)<break/>T3 (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All SUM, if pulp is not involved</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No previous biopsy<break/>WLE (12)<break/>Partial excision of the appliance, removal of the lesion, and the nearby paronychium (47)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healing by secondary intention (52) <break/><break/>FTSG (3 patients) <break/><break/>Flap (1) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Local recurrences at 24 and 32 months treated by amputation (2)<break/>Spicules (7)<break/>Epidermal cysts (2)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No functional discomfort (20)<break/>Moderate discomfort (14) Aesthetic discomfort was judged to be absent (29) Moderate aesthetic discomfort (8) Severe aesthetic discomfort (2)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">120 months (NA)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chow et al., J Plast Reconstru Surg, 2013 [<xref rid="B33-jcm-14-05932" ref-type="bibr">33</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case report<break/><break/>1M with SUM in situ<break/><break/>41 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Right T1 (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SUM in situ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biopsy <break/>10 mm <break/>WLE with a layer of bone </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immediate FTSG <break/>(harvested from the groin)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acceptable cosmetic result (assessed by surgeon)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 months</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Duarte et al., Dermatol, 2010 [<xref rid="B34-jcm-14-05932" ref-type="bibr">34</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case report <break/><break/>1F with SUM in situ<break/><break/>61</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Right F1 (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SUM in situ </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Excisional biopsy<break/>3 weeks later <break/>3 mm margin WLE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FTSG taken from the arm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No local recurrence or metastasis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thumb function completely preserved</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 months</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High et al., Arch Dermatol, 2004 [<xref rid="B32-jcm-14-05932" ref-type="bibr">32</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective<break/><break/>7 patients (5F, 2M) with SUM in situ<break/><break/>4 patients treated by WLE<break/><break/>MA 56 (NA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Right hand (1): F2 <break/>Left hand (2): F2 (1), F5 (1)<break/>Right foot (1): T1 (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SUM in situ </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Previous biopsy <break/>MOHS surgery: 1 stage (3)<break/>2 stages (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FTSG taken from the arm (3)<break/><break/>cross finger flap (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Recurrence: (1) treated by revisional amputation </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 months (10&#8211;29)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sinno et al., J Plast Surg Hand Surg, 2015 [<xref rid="B21-jcm-14-05932" ref-type="bibr">21</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective<break/><break/>35 patients with melanoma of the hand (24F, 11M)<break/><break/>18 patients with SUM <break/><break/>10 patients with SUM treated by WLE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F1 (8)<break/>F2 (12)<break/>F3 (3)<break/>F5 (3)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Melanomas in situ (7)<break/>Invasive Melanoma T2 (1 patients)<break/>B = 2.5 mm<break/>Invasive Melanoma T3 (2); B = 3.00 mm and B = 3.08 mm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 mm </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FTSG (3)<break/>Paronychial advancement flap + FTSG (3)<break/>Paronychial advancement flap + forearm flap + FTSG (1)<break/>Paronychial advancement flap + FTSG Volar Flap FTSG (1)<break/>FTSG Volar and dorsal advancement flaps (1)<break/>FTSG Local advancement flap (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Revisional amputation (3)<break/>Unknown (1)<break/>Deceased (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47 months (7&#8211;74)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Smock et al., J Plast Reconstr Aesthet Surg, 2010 [<xref rid="B35-jcm-14-05932" ref-type="bibr">35</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case report <break/>1M<break/><break/>44</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Right F1 (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ulcerated SUM Breslow of 1.2 mm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Previous Biopsy<break/>10 mm, including the periosteum</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immediate reconstruction by dermal matrix (INTEGRA)<break/>STSG 3 weeks later</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">None</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fully functional thumb and a good cosmetic result<break/>Went back to job at 4 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 months</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bjedov et al., Acta Dermato Venereol Croat, 2019 [<xref rid="B36-jcm-14-05932" ref-type="bibr">36</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case report (1)<break/>F, 31</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Left F1 (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SUM in situ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Several nail matrix biopsies<break/><break/>5 mm, with periosteum<break/><break/>Mohs analysis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pedicled innervated Fascio-cutaneous Foucher&#8217;s flap <break/>The donor site was covered with an FTSG taken from the volar side of the elbow.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">None</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The hand was fully functional, and the patient was very satisfied with the appearance of the thumb <break/>Full sensory cortical reorientation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 months</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oh et al., J Am Acad Dermatol, 2023 [<xref rid="B22-jcm-14-05932" ref-type="bibr">22</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective<break/><break/>140 patients with SUM <break/>107 with conservative treatment<break/>(57F, 50H)<break/>Mean age: 56</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F1,2,3,4,5 (71)<break/>T1,2,3,4,5 (36)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">If no bone invasion (MRI + biopsy)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biopsy and MRI<break/>at least 3 to 4 mm, with periosteum</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Recurrence (23 patients):<break/>Local recurrence (15)<break/>Distant recurrences (8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45 months (14&#8211;76) </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Motta et al., Arch Dermatol, 2007 [<xref rid="B37-jcm-14-05932" ref-type="bibr">37</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case report<break/><break/>12 years old, F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Right F1 (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SUM in situ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biopsy<break/>WLE with Mohs Micrographic analysis<break/>5&#8211;10 mm (lateral)<break/>5 mm (proximal and distal edges)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Two stages<break/><break/>Second stage (1 week later)<break/>microvascular composite onychocutaneous free flap from the right first toe</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Normal nail growth and full mobility of the interphalangeal thumb joint were present</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 months</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wollina et al., Dermatol Ther, 2019 [<xref rid="B23-jcm-14-05932" ref-type="bibr">23</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective<break/>Series of 12 patients with SUM)<break/><break/>6 patients with conservative treatment (2F, 4M)<break/><break/>76 (NA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Right foot T1 (2)<break/>T3 (1)<break/>Left foot:<break/>T1 (3)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SUM with Breslow between 1.6 mm and 4.8 mm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Wide excision (4)<break/>Excision with delayed Mohs surgery (2)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Full-thickness skin transplantation. <break/><break/>One patient refused, second intention healing</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Local relapse (2)<break/>Later metastasis (1) <break/>Satellites only (1 patient, B = 2.55)<break/>Liver, pancreas, spleen, lymph nodes, stomach, adrenal glands, greater omentum, CNS (1, with Breslow = 4.8 mm)<break/>In transit, lymph node regional, pericardium (1, with Breslow = 3.20)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sentinel Lymph node (4), with micro-invasion (1)<break/>Polychemotherapy for later metastasis (1)<break/>Transit metastases treated by erbium YAG-laser as a palliative measure (1)<break/>interferon-alfa therapy for 9 years after surgery, satellite metastasis (1)<break/>Adjuvant radiotherapy (1)<break/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">104 months (17&#8211;208)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Crisan et al., Acad Dermatol Venereol, 2017 [<xref rid="B31-jcm-14-05932" ref-type="bibr">31</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective<break/><break/>Series of 7 patients (3F, 4H)<break/><break/>64 (NA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F1 (3)<break/>F4 (3)<break/>T1 (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SUM in situ <break/><break/>pT1a (1)<break/>pT1b (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WLE (7)<break/>NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">First stage: vacuum-assisted closure<break/><break/>Second stage: FTSG (5) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Second stage amputation (2 patients) for: <break/>-DIP joint arthritis (1)<break/>-Positive margin (1) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">At 6 weeks, the 5 patients grafted could resume normal activity<break/>Good cosmetic and functional </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 months (NA)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lee et al., Plast Reconstr Surg, 2017 [<xref rid="B24-jcm-14-05932" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective<break/><break/>41 patients with conservative treatment (21M, 20F)<break/><break/>51.1 (NA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fingers: 25 <break/>Toes: 16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SUM with Breslow thickness of &#8804;2 mm on preoperative biopsy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preoperative biopsy<break/>5 mm with periosteum excised<break/>(10 mm margin if invasive lesion)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immediate reconstruction by SCIP flap with a final thickness ranging from 1.5 to 4 mm after defatting<break/><break/>(Scouted with Doppler)<break/><break/><break/>End-to-end anastomosis with digital artery and dorsal vein<break/><break/>Donor site primary closing</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Necrosis of the flap (1) (arterial insufficiency) Venous congestion (3) with partial necrosis of the flap<break/>Seroma of the donor site (1). <break/>Recurrences:<break/>-local recurrence (1)<break/>-metastasis in transit (1) Second surgical stage until degreasing (12)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Average healing time: 15 days <break/>Questionnaire carried out on 26 patients: WLE in the upper limb (14):<break/>The mean Quick-DASH score was 1.3 (range 0 to 6.8).<break/>WLE in the lower limb (12): FFI survey for foot lesions.<break/>mean score was 3.1 (range 0 to 8.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31 months (NA)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hayashi et al., Dermatol Surg, 2012 [<xref rid="B38-jcm-14-05932" ref-type="bibr">38</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case report<break/>(1M), 52 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Left F3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SUM in situ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No biopsy <break/>5 mm with excision of periosteum</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immediate reconstruction with artificial dermis (PELNAC)<break/><break/>Second stage at 4 weeks with FTSG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No recurrency <break/>No metastasis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Good cosmetic results </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 months<break/>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sureda et al., Br J Dermatol, 2011 [<xref rid="B25-jcm-14-05932" ref-type="bibr">25</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective <break/><break/>Series of 7 patients (5F, 2M)<break/><break/>MA 58 y</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F1 (2), F2 (2), F4 (1)<break/>T1 (2)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SUM in situ (5) <break/>or <break/>minimally invasive SUM (2)<break/><break/>(Breslow 0.2 and 0.15)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biopsy systematically<break/>5&#8211;10 mm<break/>Deep margin was bone contact</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immediate FTSG taken from the internal aspect of an arm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No recurrence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Interrogation of patient and observer:<break/>High level of satisfaction, a good functional and quite good cosmetic result.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45 months (24&#8211;84)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neczyporenko et al., J Eur Acad Dermatol Venereol, 2014 [<xref rid="B26-jcm-14-05932" ref-type="bibr">26</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective<break/><break/>Series of 11 patients (8F, 3M)<break/><break/>48 (NA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Right hand: F1 (3), F2 (1), F5 (1)<break/>Left hand: F1 (1) F2 (1)<break/>T1 (3), T2 (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Melanoma in situ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biopsy systematically (tangential or punch)<break/>6 mm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immediate FTSG (6)<break/><break/>Secondary intention and delayed FTSG (5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tendon sheath hematoma (1)<break/>Lymphangitis post (1)<break/>Recurrence treated by secondary amputation and sentinel node (2) (7- and 11 years post op)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healing by secondary intention and grafting were fully satisfactory, cosmetically and functionally</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">65 months (5&#8211;167)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terushkin et al., Dermatol Surg, 2016 [<xref rid="B27-jcm-14-05932" ref-type="bibr">27</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective<break/><break/>Series of 40 patients (21F, 19M)<break/><break/>63 (NA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WLE in cases of extensive SUM (&gt;40%<break/>of the bed)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Excisional biopsy with Mohs micrograph, <break/>Supra Periosteum dissection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Second intention<break/>FTSG<break/>STSG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Recurrences (5) Second operation with complete excision of the matrix (2) Amputation (2) Death due to metastasis (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">76 months (2&#8211;276)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rayatt et al., Plast Reconstr Aesthet Surg, 2007 [<xref rid="B28-jcm-14-05932" ref-type="bibr">28</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective<break/><break/>Series of 4 patients<break/><break/>56 (NA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F1 (4)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SUM without deep margin clinically involved<break/><break/>Breslow 0.9 mm to 4 mm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All had initial biopsies to confirm the diagnosis<break/>10 mm including the periosteum</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immediate:<break/>-Foucher flap (1)<break/>-Flag flap (2)<break/><break/>Delayed reconstruction (flag flap) (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Recurrence at 36 months treated by amputation (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Usefully maintain function. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72 months (&#8722;117)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Imakado et al., J Dermatol, 2008 [<xref rid="B29-jcm-14-05932" ref-type="bibr">29</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective<break/><break/>Series of 2 patients (1M, 1F)<break/><break/>50 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Left F3 (1)<break/>Right F5 (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SUM in situ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All the nail apparatus with nail folds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immediate FTSG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No recurrence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27 months (6&#8211;48)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liu et al., Medicina, 2020 [<xref rid="B30-jcm-14-05932" ref-type="bibr">30</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective <break/><break/>Series of 4 patients with malignant tumor of nail apparatus<break/><break/>3 patients with SUM suspicion (1F, 2M)<break/><break/>MA 55 y</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Left T1 (1)<break/>Right T1 (2)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SUM in situ (2)<break/><break/>hyperpigmentation in basal layer of epidermis (1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Previous biopsy (2)<break/>WLE<break/>Adequate margin control confirmed by intraoperative frozen sections</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Two-stage reconstruction<break/>Immediate acellular dermal matrix (PELNAC)<break/><break/>At 10 days, the acellular dermal matrix was removed and re-dressed with a new one at the outpatient clinic<break/><break/>FTSG at 3 weeks </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No Recurrence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">These patients experienced minimal change in body contour, mild but acceptable functional deficit, and satisfying aesthetic results.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9 months (5&#8211;13)</td></tr></tbody></table></table-wrap></floats-group></article></pmc-articleset>